{"meta":{"query_hash":"9068ed2785af","filters":{"venue":"npj Breast Cancer"},"cohort_total":84,"direct_labels_cover":0,"predictions_cover":84,"exported":84,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9068ed2785af","api":"https://metacan.xera.ac/api/v1/cohort?venue=npj+Breast+Cancer"},"results":[{"id":"W2254049207","doi":"10.1038/npjbcancer.2015.9","title":"Preventing breast cancer now by acting on what we already know","year":2015,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Foundation for Barnes-Jewish Hospital; Breast Cancer Research Foundation","keywords":"Menarche; Breast cancer; Demography; Menopause; Medicine; Incidence (geometry); Quarter (Canadian coin); Cancer; Gynecology; Gerontology; Internal medicine; History","score_opus":0.015822233236680673,"score_gpt":0.3270193469797726,"score_spread":0.3111971137430919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2254049207","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001832304,0.031416964,0.000006622894,0.0066418713,0.9431118,0.0011543994,0.013275126,0.00036214513,0.0021988014],"genre_scores_gemma":[0.003969807,0.054636084,0.000020698355,0.0004964568,0.91500497,0.0005976472,0.0011548748,0.00044554885,0.023673931],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940523,0.00010523137,0.0008041996,0.0014789518,0.0023193455,0.0012400061],"domain_scores_gemma":[0.996054,0.0002831553,0.00087156263,0.0009214248,0.0010873801,0.00078250875],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0004996358,0.0011050801,0.0016056179,0.00026211728,0.00022639817,0.00036099227,0.00047233707,0.0014644285,0.0035000853],"category_scores_gemma":[0.00009075798,0.0009595754,0.0004687455,0.00040545186,0.00015469534,0.00064594805,0.00019236022,0.0025848513,0.00017740234],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094613375,0.00016381168,0.002026987,0.00044997846,0.0003991125,0.000022294214,0.000238902,0.000010113045,0.00010171223,4.624063e-7,0.6813473,0.31429318],"study_design_scores_gemma":[0.003092201,0.00013895395,0.001454837,0.010831558,0.0008316536,0.000075194665,0.00032067412,0.000040727213,0.00008486162,0.0000079930505,0.98216337,0.00095798605],"about_ca_topic_score_codex":0.016549103,"about_ca_topic_score_gemma":0.0042256415,"teacher_disagreement_score":0.31333518,"about_ca_system_score_codex":0.0038902396,"about_ca_system_score_gemma":0.003440463,"threshold_uncertainty_score":0.99993366},"labels":[],"label_agreement":null},{"id":"W2337607123","doi":"10.1038/npjbcancer.2016.9","title":"TNF is a key cytokine mediating neutrophil cytotoxic activity in breast cancer patients","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Neutrophil, Myeloperoxidase and Oxidative Mechanisms","field":"Immunology and Microbiology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Fonds de Recherche du Québec - Santé; National Cancer Institute; Conquer Cancer Foundation; National Institutes of Health; Geoffrey Beene Cancer Research Center; Breast Cancer Research Foundation","keywords":"Cytotoxicity; Cytotoxic T cell; Breast cancer; Tumor necrosis factor alpha; Medicine; Cancer; Immunology; Cancer research; Internal medicine; Biology; In vitro","score_opus":0.010330702889234253,"score_gpt":0.24132856272135642,"score_spread":0.23099785983212218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2337607123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508555,0.0003559537,0.00003602966,0.008250147,0.0011203506,0.00041719284,0.0044391225,0.00009467856,0.00020100655],"genre_scores_gemma":[0.99646777,0.0005971604,0.00001700855,0.0014278657,0.0002983447,0.00035521307,0.000032047043,0.00006787534,0.0007367281],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974623,0.00025349518,0.00042243846,0.0008111138,0.00014049723,0.0009101687],"domain_scores_gemma":[0.99886405,0.00010326973,0.00028110025,0.0004239204,0.00023478916,0.00009286694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017104673,0.00047069942,0.0005873257,0.00022896573,0.00019660442,0.000021679754,0.0003863205,0.00034721007,0.005722889],"category_scores_gemma":[0.000016163945,0.00033004297,0.00014747902,0.00035639104,0.00021490977,0.00042586433,0.0002128031,0.00042262758,0.00047427783],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006822964,0.0003046287,0.087872386,0.000025133268,0.00013598146,0.000011337522,0.00023711681,0.0000021113603,0.8328395,0.00008301991,0.0011742134,0.076632276],"study_design_scores_gemma":[0.0043116612,0.000081010745,0.57181233,0.00028050138,0.000044614775,0.000042238265,0.000020898053,0.0000017840426,0.42031744,0.00009353857,0.0025402715,0.00045368393],"about_ca_topic_score_codex":0.0024714447,"about_ca_topic_score_gemma":0.0004740835,"teacher_disagreement_score":0.48393998,"about_ca_system_score_codex":0.00057636376,"about_ca_system_score_gemma":0.00022955918,"threshold_uncertainty_score":0.9999152},"labels":[],"label_agreement":null},{"id":"W2346853311","doi":"10.1038/npjbcancer.2016.7","title":"DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; National Human Genome Research Institute; National Institutes of Health","keywords":"Breast cancer; DNA methylation; Biology; Cancer; Epigenetics; genomic DNA; Gene; microRNA; Cancer research; Gene expression; Genetics","score_opus":0.008827057926447526,"score_gpt":0.24618278996116574,"score_spread":0.23735573203471821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346853311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96876585,0.02453138,0.00011601572,0.0020567586,0.0004941553,0.00059391564,0.0033952307,0.0000117000745,0.000035017307],"genre_scores_gemma":[0.9718757,0.025253927,0.00006121445,0.00063037954,0.0013934704,0.000559416,0.000036225538,0.000059282927,0.00013037685],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980465,0.00009823773,0.00032504444,0.000821806,0.00022384652,0.00048452392],"domain_scores_gemma":[0.99885434,0.000064390915,0.00014988522,0.0006258339,0.0001232783,0.00018228394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015513891,0.00032752682,0.0002892978,0.00003952918,0.00013090257,0.000054832835,0.00038130837,0.00015702295,0.00031538316],"category_scores_gemma":[0.00002257192,0.00021157826,0.00007964197,0.00010930085,0.00013698805,0.000008597909,0.00039357843,0.000120681776,0.000006570233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030844612,0.00015108466,0.43077573,0.000008260098,0.00008356874,0.0000064826927,0.00020671352,0.00016913994,0.540621,0.0000025394004,0.00090262666,0.026764417],"study_design_scores_gemma":[0.0024944416,0.00011394526,0.90723413,0.00014491765,0.00008505331,0.000014942064,0.0001290501,0.0000119223105,0.07701995,0.000050809595,0.012283804,0.00041702695],"about_ca_topic_score_codex":0.012072769,"about_ca_topic_score_gemma":0.028064921,"teacher_disagreement_score":0.4764584,"about_ca_system_score_codex":0.00024017676,"about_ca_system_score_gemma":0.00036157417,"threshold_uncertainty_score":0.99450594},"labels":[],"label_agreement":null},{"id":"W2407306171","doi":"10.1038/npjbcancer.2016.14","title":"Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Ottawa Hospital; University of Alberta; Ontario Institute for Cancer Research; Juravinski Hospital; McMaster University; Health Sciences Centre; Mount Sinai Hospital; University of British Columbia","funders":"Cure Brain Cancer Foundation; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Ontario; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Intraclass correlation; External quality assessment; Reproducibility; Medicine; Nuclear proliferation; Protocol (science); Breast cancer; Core biopsy; Confidence interval; Biomarker; Multicenter study; Nuclear medicine; Pathology; Statistics; Internal medicine; Cancer; Mathematics; Randomized controlled trial","score_opus":0.024729871601926665,"score_gpt":0.3991916576170507,"score_spread":0.37446178601512403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407306171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96383667,0.000012483826,0.007445053,0.0010778131,0.0002408026,0.02335251,0.0038025102,0.000014275084,0.00021789873],"genre_scores_gemma":[0.96392155,0.000006220267,0.00091676624,0.000022621469,0.00026402366,0.034748737,0.000062632236,0.000014727278,0.000042707306],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99925816,0.00002579293,0.00022962016,0.00022086024,0.00015622318,0.0001093173],"domain_scores_gemma":[0.9990297,0.000013083643,0.00017062377,0.00016372414,0.00058541406,0.00003746012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009193323,0.000100471654,0.00014725,0.00003843764,0.000025457066,0.000007749371,0.00009044746,0.000051089733,0.00009090242],"category_scores_gemma":[0.00004150948,0.00007193358,0.0000601827,0.00005359103,0.00007125581,0.000021715365,0.00003232604,0.000013178264,3.6980634e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024201754,0.0012335943,0.1144694,0.0001751806,0.00080036913,7.876005e-7,0.00021891303,0.00010169272,0.7596403,0.00021202274,0.0006523672,0.09829367],"study_design_scores_gemma":[0.019052867,0.00034326297,0.021426845,0.00016993892,0.000072797324,0.0000035360197,0.00005675433,0.00019743954,0.952561,0.000029028202,0.0059458115,0.00014068795],"about_ca_topic_score_codex":0.000036556492,"about_ca_topic_score_gemma":0.000036452813,"teacher_disagreement_score":0.19292077,"about_ca_system_score_codex":0.0000787903,"about_ca_system_score_gemma":0.00013572846,"threshold_uncertainty_score":0.29333663},"labels":[],"label_agreement":null},{"id":"W2470412971","doi":"10.1038/npjbcancer.2016.22","title":"The molecular landscape of high-risk early breast cancer: comprehensive biomarker analysis of a phase III adjuvant population","year":2016,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Oncology; Medicine; Internal medicine; Population; Cancer; Cancer research","score_opus":0.009950373896513452,"score_gpt":0.28530443092892915,"score_spread":0.2753540570324157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470412971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98909754,0.0047544055,0.00025339,0.0022836558,0.0002403753,0.00035695825,0.0029342547,0.000027445443,0.000051978528],"genre_scores_gemma":[0.99646217,0.0029934878,0.000029090628,0.00016723979,0.000090132664,0.000072429626,0.000047833,0.000029316072,0.00010831711],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99818933,0.000101459984,0.0006271437,0.00029939206,0.00048017214,0.00030252466],"domain_scores_gemma":[0.9981527,0.0000990274,0.00061721593,0.0005393573,0.00048467537,0.00010706743],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018731914,0.00023142793,0.0007049521,0.00027547838,0.00009498047,0.000012428739,0.00016308865,0.00011056969,0.0010653592],"category_scores_gemma":[0.0000069516113,0.00012760826,0.00042144346,0.0009944437,0.00023081894,0.000090384594,0.00003679278,0.0000896568,0.0000018778384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016957885,0.00020609656,0.34647578,0.00004867448,0.0073284805,0.000006806192,0.00018001525,0.000033640503,0.117080055,0.00004455722,0.000492258,0.5111458],"study_design_scores_gemma":[0.010466962,0.00013222432,0.98094314,0.00030775397,0.0030624706,0.000026231139,0.0000850577,0.00037404292,0.0037232228,0.000018119821,0.00068577676,0.0001749991],"about_ca_topic_score_codex":0.050782483,"about_ca_topic_score_gemma":0.0016409071,"teacher_disagreement_score":0.63446736,"about_ca_system_score_codex":0.00018517666,"about_ca_system_score_gemma":0.00016293277,"threshold_uncertainty_score":0.9998478},"labels":[],"label_agreement":null},{"id":"W2544829712","doi":"10.1038/npjbcancer.2015.14","title":"αB-crystallin expression in breast cancer is associated with brain metastasis","year":2015,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Breast cancer; Brain metastasis; Immunohistochemistry; Oncology; Metastasis; Medicine; Proportional hazards model; Estrogen receptor; Cancer research; Internal medicine; Tissue microarray; Cancer; Pathology","score_opus":0.022812973232451246,"score_gpt":0.3123760208703252,"score_spread":0.28956304763787394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544829712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98557585,0.0015657383,0.00025000153,0.009325052,0.00009840152,0.00052335777,0.001721226,0.00003151776,0.00090885704],"genre_scores_gemma":[0.9959609,0.0001895648,0.0001507636,0.0010384059,0.00027788774,0.00040901944,0.00010684412,0.00006676541,0.0017998299],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977583,0.00022118469,0.00025004742,0.00059948093,0.00055352534,0.000617441],"domain_scores_gemma":[0.9987493,0.000016021637,0.000089016015,0.00043127977,0.0003874622,0.00032691346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004715476,0.00026612144,0.00029193555,0.00010302271,0.00006505063,0.00004466172,0.00030728552,0.00024891307,0.00066514267],"category_scores_gemma":[0.000061176084,0.00021581848,0.0000694191,0.00035542826,0.00010946413,0.000017885113,0.00018686678,0.00026253154,0.000013485131],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020307598,0.0004199213,0.1059514,0.00006194543,0.0003306346,0.00007223183,0.00040354452,0.0008021073,0.78633595,0.0000054302245,0.069045305,0.034540758],"study_design_scores_gemma":[0.013445995,0.00060109753,0.25171497,0.0013190347,0.000108424094,0.00037234896,0.0006029311,0.00090021687,0.6331208,0.000099176454,0.0956382,0.0020768489],"about_ca_topic_score_codex":0.0033749389,"about_ca_topic_score_gemma":0.0030790395,"teacher_disagreement_score":0.15321521,"about_ca_system_score_codex":0.00034429622,"about_ca_system_score_gemma":0.0009386325,"threshold_uncertainty_score":0.8800822},"labels":[],"label_agreement":null},{"id":"W2587895918","doi":"10.1038/s41523-016-0003-5","title":"Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"Cancer Research UK; Canadian Institutes of Health Research; Government of Ontario; Ontario Institute for Cancer Research","keywords":"Oncology; Medicine; Breast cancer; Internal medicine; Gene signature; Druggability; Tamoxifen; Cohort; Hazard ratio; Cancer; Bioinformatics; Gene; Biology; Gene expression","score_opus":0.010883199883549792,"score_gpt":0.29636171687394103,"score_spread":0.28547851699039123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587895918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793998,0.002059237,0.00023153494,0.014111674,0.0007403088,0.0005067195,0.0015348374,0.000027044644,0.0013888151],"genre_scores_gemma":[0.9975116,0.00041826867,0.000094282805,0.00031055228,0.00067158975,0.00036456608,0.000079699836,0.000047677247,0.0005017558],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980885,0.00005149646,0.00039444029,0.0006881935,0.00038802339,0.0003893513],"domain_scores_gemma":[0.9978296,0.000010714589,0.00041722375,0.0010342404,0.0005288811,0.00017933238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013303895,0.00035659393,0.0004112843,0.00007337587,0.00032527483,0.0000665801,0.00056165043,0.00012645377,0.00027387115],"category_scores_gemma":[0.000026949532,0.00031287005,0.00011970673,0.000083235,0.0004103032,0.000030903127,0.000188418,0.00010598622,0.000011709697],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009563182,0.00019132135,0.1404937,0.00012607563,0.0009631488,0.0000128807,0.0011578698,0.00026470414,0.81529415,0.00047628832,0.008904303,0.031159215],"study_design_scores_gemma":[0.0010384608,0.000059963793,0.84427243,0.00020341492,0.00015957649,0.000020170133,0.00021641441,0.0000071169907,0.15306965,0.00015020736,0.00048045817,0.00032212984],"about_ca_topic_score_codex":0.012240357,"about_ca_topic_score_gemma":0.003824285,"teacher_disagreement_score":0.70377874,"about_ca_system_score_codex":0.00009429546,"about_ca_system_score_gemma":0.00021829075,"threshold_uncertainty_score":0.99993235},"labels":[],"label_agreement":null},{"id":"W2604847249","doi":"10.1038/s41523-017-0013-y","title":"Breast cancers are rare diseases—and must be treated as such","year":2017,"lang":"en","type":"editorial","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Oncology; Cancer","score_opus":0.006888642626517182,"score_gpt":0.27208320482393233,"score_spread":0.26519456219741516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604847249","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020856649,0.048562206,0.0000073613382,0.0058663813,0.75970453,0.0016050213,0.15941657,0.00025832633,0.0037229478],"genre_scores_gemma":[0.13340937,0.016113486,0.000015576403,0.00045593613,0.83166766,0.0013539714,0.0068680146,0.00038625952,0.009729751],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99606305,0.00009773871,0.00040817462,0.0017483616,0.0007783909,0.00090428785],"domain_scores_gemma":[0.9966625,0.000062712345,0.0006855361,0.0013957808,0.00072208524,0.0004713899],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008414477,0.0011357677,0.0010613105,0.00011240267,0.00063197245,0.0002822733,0.0007142733,0.0012603047,0.0002783764],"category_scores_gemma":[0.00010413645,0.0010451751,0.00035636805,0.000100147416,0.0006082306,0.00003138897,0.000520013,0.0005383462,0.000021658045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014825457,0.00010585511,0.024286136,0.00020635764,0.0014641436,0.000090026464,0.000056710767,0.00000840566,0.00012855347,0.0000030974925,0.96315205,0.009016134],"study_design_scores_gemma":[0.003519725,0.00010381293,0.1020951,0.0006748369,0.0011814936,0.00024761676,0.00012265716,0.0000017149753,0.0001895908,0.000013680754,0.890544,0.0013057615],"about_ca_topic_score_codex":0.0138694765,"about_ca_topic_score_gemma":0.005815479,"teacher_disagreement_score":0.15254857,"about_ca_system_score_codex":0.0007725465,"about_ca_system_score_gemma":0.0018656211,"threshold_uncertainty_score":0.99919987},"labels":[],"label_agreement":null},{"id":"W2623464423","doi":"10.1038/s41523-017-0024-8","title":"The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; Oxnard Foundation; Pennsylvania Department of Health; Stop Cancer; Avon Foundation for Women; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; CHEK2; PALB2; Odds ratio; Oncology; Medicine; Germline mutation; Cancer; Genetics; Internal medicine; Mutation; Biology; Gene","score_opus":0.008631985747489999,"score_gpt":0.2878752612757638,"score_spread":0.27924327552827377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623464423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97497535,0.0035555677,0.00018228653,0.006370779,0.0016657548,0.0006904349,0.012432618,0.000017091683,0.000110100824],"genre_scores_gemma":[0.991022,0.0062520746,0.00006114549,0.00028235934,0.0013630355,0.0007215585,0.000049635382,0.000053142816,0.00019506428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997332,0.00020130783,0.0005548897,0.0008527444,0.00037916275,0.000679917],"domain_scores_gemma":[0.997014,0.00002902323,0.0005256976,0.0014081725,0.00082825375,0.00019484799],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064290717,0.00036376633,0.00038965233,0.00006285955,0.0006237101,0.00010605257,0.0009013525,0.0003083242,0.00031412914],"category_scores_gemma":[0.00006927172,0.00029985307,0.00019340066,0.00018784172,0.0004978887,0.000031777046,0.00037302612,0.0002586104,0.000010211841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013098589,0.00010461714,0.621515,0.000023809434,0.00020672983,0.0000025831157,0.00009005844,0.0014602243,0.21975867,0.00003300072,0.0017500207,0.15374543],"study_design_scores_gemma":[0.0015438892,0.000035508252,0.9795063,0.00009859867,0.00010125151,0.000053668744,0.00006989871,0.00021370524,0.014820801,0.00008239673,0.0031010269,0.00037294676],"about_ca_topic_score_codex":0.027353175,"about_ca_topic_score_gemma":0.07094917,"teacher_disagreement_score":0.3579913,"about_ca_system_score_codex":0.00071318576,"about_ca_system_score_gemma":0.0013975307,"threshold_uncertainty_score":0.99994534},"labels":[],"label_agreement":null},{"id":"W2753529942","doi":"10.1038/s41523-017-0040-8","title":"Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design","year":2017,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; University of Victoria; University of British Columbia","funders":"Canadian Cancer Society Research Institute; National Cancer Institute; National Institutes of Health; ECOG-ACRIN Cancer Research Group; Harvard University; American College of Radiology Imaging Network; Breast Cancer Research Foundation; Susan G. Komen for the Cure","keywords":"Medicine; Weight loss; Breast cancer; Overweight; Cancer; Randomized controlled trial; Body mass index; Weight change; Internal medicine; Obesity; Physical therapy; Oncology","score_opus":0.08614657863996368,"score_gpt":0.4208260353502067,"score_spread":0.334679456710243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753529942","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16344506,0.8240455,0.0000055454802,0.00005491316,0.00027079164,0.010973521,0.0011239301,0.000016771077,0.00006397549],"genre_scores_gemma":[0.13457264,0.8571131,0.000025018699,0.000010029814,0.00065812055,0.0072282623,0.000013317123,0.000099836754,0.0002796571],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99535006,0.00078089145,0.0015172673,0.00084830605,0.0008946608,0.0006087962],"domain_scores_gemma":[0.9958502,0.00046030423,0.0020951,0.001040889,0.0003064209,0.00024710238],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00140459,0.00086752255,0.006532453,0.00019872784,0.00013864387,0.000044026146,0.0003517568,0.00024775948,0.000572344],"category_scores_gemma":[0.000032832726,0.00043585524,0.00048088256,0.00031554015,0.00055494165,0.0001244151,0.000072549374,0.00039908502,0.0000015050033],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40646586,0.001198875,0.0024997233,0.0009889659,0.0016540947,0.000024216843,0.0018851297,0.0000040205928,0.000002251757,0.0000018844864,0.0000050887033,0.58526987],"study_design_scores_gemma":[0.94385594,0.005644581,0.004725795,0.018263577,0.008412152,0.00017218388,0.0002534743,0.00009206439,0.000007382556,0.000016971933,0.017941995,0.00061387464],"about_ca_topic_score_codex":0.022920744,"about_ca_topic_score_gemma":0.0012689731,"teacher_disagreement_score":0.584656,"about_ca_system_score_codex":0.0014079459,"about_ca_system_score_gemma":0.0028736843,"threshold_uncertainty_score":0.9998093},"labels":[],"label_agreement":null},{"id":"W2768048855","doi":"10.1038/s41523-017-0046-2","title":"Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk","year":2017,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Breast cancer; Oncology; Cancer; Gene; Genetics; Medicine; Biology; Internal medicine","score_opus":0.008589174223133095,"score_gpt":0.2782639418366811,"score_spread":0.26967476761354797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768048855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5417941,0.07273772,0.00042160167,0.015780646,0.1163541,0.004945752,0.24651404,0.000120916746,0.0013310913],"genre_scores_gemma":[0.9378352,0.027784957,0.000016978773,0.00057735224,0.014375619,0.0012249112,0.0016442304,0.00014004657,0.016400691],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9960698,0.00039630456,0.00077214255,0.0013732159,0.00057107466,0.0008174679],"domain_scores_gemma":[0.9958391,0.00002111339,0.00080973,0.0015276239,0.0013929867,0.00040944578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000535575,0.00071205985,0.00080200814,0.00013603445,0.00044455397,0.00010150829,0.0008762469,0.0010536615,0.00077240076],"category_scores_gemma":[0.00007851128,0.00061316777,0.00045611942,0.00024444543,0.0004923721,0.000020942101,0.0003202527,0.0006732729,0.000010777989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003953446,0.0005343838,0.25770697,0.00025597351,0.000485885,0.000011462269,0.000111453555,0.00046845575,0.027658064,0.0000053299045,0.6493836,0.059424955],"study_design_scores_gemma":[0.0019180445,0.000080760736,0.93348205,0.00057216024,0.0004949998,0.00011177006,0.00007757975,0.00017046907,0.001159567,0.000053023687,0.06109196,0.0007876289],"about_ca_topic_score_codex":0.030606251,"about_ca_topic_score_gemma":0.056503855,"teacher_disagreement_score":0.67577505,"about_ca_system_score_codex":0.0005354068,"about_ca_system_score_gemma":0.002837081,"threshold_uncertainty_score":0.99963194},"labels":[],"label_agreement":null},{"id":"W2769275606","doi":"10.1038/s41523-017-0049-z","title":"Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy","year":2017,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; University of Toronto","funders":"National Institute for Health and Care Research; Breast Cancer Research Foundation","keywords":"Breast cancer; Medicine; Internal medicine; Oestrogen receptor; Aromatase; Estrogen; Endocrinology; Progesterone receptor; Mastectomy; Cancer; Estrogen receptor","score_opus":0.004951322554612665,"score_gpt":0.2521952689948242,"score_spread":0.24724394644021153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769275606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875886,0.0037274612,0.000003065603,0.0046566394,0.0003684732,0.00053512893,0.0023708737,0.00002056208,0.0007292283],"genre_scores_gemma":[0.99331504,0.0017496041,0.000058818452,0.00083421904,0.00056480156,0.003164631,0.00007622716,0.00008421449,0.0001524191],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749714,0.00010285096,0.0002925678,0.0009245357,0.0003024064,0.00088051014],"domain_scores_gemma":[0.9986629,0.000008762922,0.00021768242,0.00076807424,0.00016286454,0.00017973912],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017004389,0.00049708,0.00050305284,0.000121987345,0.00015411158,0.000080489284,0.0004740914,0.00024220532,0.00047016086],"category_scores_gemma":[0.000012306897,0.00047598445,0.00008555926,0.00013622206,0.00027586424,0.00003219392,0.0004489956,0.00022921106,0.000015340402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003696633,0.00034882725,0.82740515,0.00009748962,0.00047433312,0.00011590222,0.0010683,0.000074455165,0.121201016,0.000008058587,0.0003087292,0.04520112],"study_design_scores_gemma":[0.0026691018,0.00008736419,0.97709817,0.00030497377,0.000044476452,0.00005847343,0.00014981047,0.000005155672,0.018012509,0.00002076827,0.001012415,0.00053681136],"about_ca_topic_score_codex":0.0031895249,"about_ca_topic_score_gemma":0.008261733,"teacher_disagreement_score":0.149693,"about_ca_system_score_codex":0.0010370099,"about_ca_system_score_gemma":0.00037357773,"threshold_uncertainty_score":0.9997692},"labels":[],"label_agreement":null},{"id":"W2793956875","doi":"10.1038/s41523-018-0056-8","title":"Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort","year":2018,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; Pathological Society of Great Britain and Ireland; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Breast cancer; Medicine; Oncology; Internal medicine; Nottingham Prognostic Index; Pathology; Hormone receptor; Lymph node; Cohort; Cancer; Biology","score_opus":0.013992167010253971,"score_gpt":0.2823321541672078,"score_spread":0.26833998715695384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793956875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98798805,0.004789542,0.000035931727,0.003757366,0.00012628926,0.00040781058,0.002614628,0.000007732006,0.00027265862],"genre_scores_gemma":[0.9953658,0.0032279072,0.00008225631,0.00031531794,0.0005998703,0.0001955165,0.00016302966,0.00001811266,0.000032170024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987358,0.00014143945,0.00033143387,0.0003764012,0.00014844452,0.00026648247],"domain_scores_gemma":[0.9991919,0.000025066727,0.0002451697,0.0002773173,0.00021811368,0.000042430973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029912818,0.00018148469,0.00032340558,0.00004140522,0.00010703241,0.000015926584,0.0001880986,0.0001032082,0.000057574318],"category_scores_gemma":[0.00001648575,0.00013828978,0.00006507027,0.00017404337,0.00021326996,0.00000946793,0.000059756425,0.00008714983,0.0000034167326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000545811,0.000065112996,0.95626503,0.000020885269,0.00026030606,0.000001019603,0.00030273665,0.0000034944958,0.026558325,0.0000696511,0.0006288278,0.015770026],"study_design_scores_gemma":[0.00050618005,0.000027960821,0.9967483,0.000033875847,0.0002340959,0.000034159104,0.000058879592,0.0000028087825,0.0017230187,0.000048723905,0.00044724077,0.00013471993],"about_ca_topic_score_codex":0.0017409887,"about_ca_topic_score_gemma":0.002546526,"teacher_disagreement_score":0.0404833,"about_ca_system_score_codex":0.000104706676,"about_ca_system_score_gemma":0.00016588473,"threshold_uncertainty_score":0.5639293},"labels":[],"label_agreement":null},{"id":"W2947470150","doi":"10.1038/s41523-019-0111-0","title":"SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Berlin Institute of Health; Deutsche Forschungsgemeinschaft; Breast Cancer Research Foundation","keywords":"Breast cancer; Metastatic breast cancer; Medicine; Internal medicine; Oncology; Cancer; Targeted therapy; Endocrine system; Hormone; Bioinformatics; Cancer research; Biology","score_opus":0.03199847053610999,"score_gpt":0.3266311783684151,"score_spread":0.2946327078323051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947470150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8555619,0.004757583,0.041626986,0.035398535,0.0034451215,0.015423674,0.042905513,0.0006684224,0.00021225856],"genre_scores_gemma":[0.9636698,0.00041702192,0.0140328575,0.008036634,0.0028542865,0.007095453,0.00025972663,0.00036551885,0.0032686987],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99642265,0.0000752547,0.0005678834,0.001142463,0.0005840157,0.0012077534],"domain_scores_gemma":[0.9971489,0.00027224692,0.00026953797,0.0008337447,0.0009294971,0.0005461115],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003330502,0.00069022237,0.0011784435,0.0002346644,0.00016455895,0.000055853547,0.00022354143,0.00011707376,0.0023151648],"category_scores_gemma":[0.000029733721,0.0005862804,0.00044262104,0.0004129428,0.000120225835,0.00034725005,0.00007883855,0.00025947538,0.00004742214],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044037204,0.0011027297,0.060478505,0.0016505551,0.0033129773,0.00005403517,0.00097405526,0.008526247,0.23002377,0.00017080942,0.00830463,0.64136446],"study_design_scores_gemma":[0.06798769,0.002602294,0.6036634,0.0023821814,0.0017740197,0.005358204,0.0005842158,0.010026919,0.05992063,0.0006537287,0.241713,0.0033336992],"about_ca_topic_score_codex":0.0010602159,"about_ca_topic_score_gemma":0.0004112454,"teacher_disagreement_score":0.63803077,"about_ca_system_score_codex":0.0010542839,"about_ca_system_score_gemma":0.0008138126,"threshold_uncertainty_score":0.9996589},"labels":[],"label_agreement":null},{"id":"W2953595023","doi":"10.1038/s41523-019-0113-y","title":"LobSig is a multigene predictor of outcome in invasive lobular carcinoma","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Council Queensland; National Health and Medical Research Council; Medical Research Council; Metro North Hospital and Health Service; Cancer Institute NSW; National Breast Cancer Foundation; Cancer Research UK","keywords":"Nottingham Prognostic Index; Invasive lobular carcinoma; Oncology; Internal medicine; Medicine; Proportional hazards model; Breast cancer; Estrogen receptor; Gene expression profiling; Bioinformatics; Cancer; Gene; Biology; Gene expression; Genetics; Invasive ductal carcinoma","score_opus":0.011775906360530797,"score_gpt":0.2577401540726026,"score_spread":0.2459642477120718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953595023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557143,0.0022330442,0.000010229403,0.00044840682,0.00026744333,0.00031772736,0.0006687207,0.000008572695,0.00047440143],"genre_scores_gemma":[0.99848914,0.0002054738,0.00009474731,0.0004741353,0.0001750958,0.00010277291,0.000043359807,0.00003072751,0.00038455793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875385,0.000030560885,0.00029364918,0.00044317456,0.00018154213,0.00029723675],"domain_scores_gemma":[0.99924624,0.000013706024,0.00012704078,0.00041984348,0.00012704163,0.00006614379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000057702982,0.0002212021,0.00032867753,0.000060679566,0.000022106307,0.0000058449,0.00018658418,0.00013502286,0.00038109295],"category_scores_gemma":[0.000013872683,0.00020113697,0.00011750039,0.00012169876,0.00008146688,0.0000062763006,0.00014132433,0.000076213524,0.00003109513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002488149,0.00009711542,0.9508379,0.00008083208,0.00013027553,0.0000045519146,0.00024514872,0.00005708325,0.046594135,0.000006818704,0.00047529326,0.0012220126],"study_design_scores_gemma":[0.0020703352,0.00007048594,0.934632,0.000056180303,0.0000355435,0.000016486483,0.00010413049,0.000015368269,0.061788693,0.000010890189,0.0010074552,0.00019245355],"about_ca_topic_score_codex":0.0023586913,"about_ca_topic_score_gemma":0.0007492916,"teacher_disagreement_score":0.016205942,"about_ca_system_score_codex":0.000107181935,"about_ca_system_score_gemma":0.00015593057,"threshold_uncertainty_score":0.8202128},"labels":[],"label_agreement":null},{"id":"W2967367406","doi":"10.1038/s41523-019-0115-9","title":"Homologous recombination DNA repair defects in PALB2-associated breast cancers","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill Genome Centre; Jewish General Hospital","funders":"National Cancer Institute; Medical Research Council; National Health and Medical Research Council; Ministerstvo Zdravotnictví Ceské Republiky; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Cycle for Survival; National Breast Cancer Foundation; National Institute for Health and Care Research; China Scholarship Council; Susan G. Komen; Univerzita Karlova v Praze; Ministry of Higher Education, Malaysia; NIHR Cambridge Biomedical Research Centre; European Commission; Breast Cancer Research Foundation; Cancer Australia; National Science Foundation","keywords":"PALB2; Genetics; Biology; Allele; Breast cancer; Germline mutation; Germline; Homologous recombination; Mutation; Gene; Cancer","score_opus":0.00452957797043336,"score_gpt":0.22556531874939034,"score_spread":0.221035740778957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967367406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956722,0.00036760478,0.000010039386,0.00022139512,0.00074111857,0.00037127084,0.00015334591,0.00008620485,0.0023767708],"genre_scores_gemma":[0.99716574,0.00013490977,0.000058474667,0.00041722626,0.00012085451,0.00012723237,0.00013705324,0.000048431957,0.00179008],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984378,0.0001124274,0.00023800059,0.0005786141,0.0001974586,0.00043569534],"domain_scores_gemma":[0.99920744,0.000011522499,0.00013829314,0.00041415793,0.0001368582,0.000091719565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025597206,0.00022043772,0.00023378078,0.00008586264,0.000042378575,0.000017469762,0.00019530149,0.00029381298,0.00037944602],"category_scores_gemma":[0.000027787652,0.00023122784,0.00014959788,0.00022467853,0.000037745725,0.000011038977,0.000093840674,0.00015270642,0.000059884653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005059524,0.00030037848,0.34264654,0.000084817184,0.0002499632,0.000030932122,0.00013197784,0.00070172484,0.63320374,0.00020168384,0.0049114274,0.017030835],"study_design_scores_gemma":[0.0046682726,0.00046517263,0.8828564,0.000265324,0.00007114459,0.00031827582,0.0001447189,0.001052205,0.104936786,0.00042034642,0.0037707838,0.0010305563],"about_ca_topic_score_codex":0.0015307005,"about_ca_topic_score_gemma":0.0027527192,"teacher_disagreement_score":0.54020983,"about_ca_system_score_codex":0.00049759407,"about_ca_system_score_gemma":0.00030932273,"threshold_uncertainty_score":0.94291973},"labels":[],"label_agreement":null},{"id":"W2979775428","doi":"10.1038/s41523-019-0130-x","title":"Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Medicine; Metastatic breast cancer; Blockade; Breast cancer; Oncology; Cancer; Chemotherapy; PD-L1; Internal medicine; Antibody; Clinical Practice; Radiation therapy; Immunotherapy; Immunology; Receptor","score_opus":0.10722042243326235,"score_gpt":0.36058413776115533,"score_spread":0.253363715327893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979775428","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077754253,0.9834521,0.000009044062,0.007435637,0.001175337,0.0030141599,0.0026865075,0.00009668737,0.0013530247],"genre_scores_gemma":[0.0038954853,0.98738307,0.0001287594,0.0016208532,0.0010371839,0.0019944478,0.00070804014,0.00026485338,0.0029673104],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99539477,0.00034393277,0.0012360865,0.0011822418,0.000930522,0.0009124724],"domain_scores_gemma":[0.9977137,0.0001359753,0.00078527216,0.0009652404,0.0001683734,0.00023147005],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005968225,0.0010477789,0.0031181234,0.0006392491,0.00009829521,0.000096123134,0.0004837482,0.00046344736,0.0034280487],"category_scores_gemma":[0.000008465719,0.0008419104,0.0009463478,0.0010374464,0.00025480348,0.00024111029,0.000118797885,0.0011103875,0.00008623681],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091990386,0.00056415476,0.002572788,0.01821264,0.002115454,0.000031277537,0.00017655603,0.000004131736,0.000018677018,0.000039277944,0.0018093268,0.97353584],"study_design_scores_gemma":[0.0099992,0.00015000279,0.03609817,0.047100563,0.007296721,0.0013983822,0.00012211749,0.00007913535,0.000024607538,0.00003215488,0.8959525,0.0017464529],"about_ca_topic_score_codex":0.009157009,"about_ca_topic_score_gemma":0.0016216707,"teacher_disagreement_score":0.97178936,"about_ca_system_score_codex":0.0023029337,"about_ca_system_score_gemma":0.0019350067,"threshold_uncertainty_score":0.9994032},"labels":[],"label_agreement":null},{"id":"W2982449517","doi":"10.1038/s41523-019-0133-7","title":"If we build it they will come: targeting the immune response to breast cancer","year":2019,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Cancer Institute","keywords":"Tumor microenvironment; Immune system; Immunotherapy; Immunology; Antigen presentation; Breast cancer; Cancer research; Medicine; Antigen; Cancer immunotherapy; Cancer; Biology; T cell; Internal medicine","score_opus":0.025922347459563594,"score_gpt":0.3392283886206269,"score_spread":0.3133060411610633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982449517","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000116845156,0.9513222,0.000007974931,0.03901526,0.0026174563,0.0029121013,0.0033932505,0.00012300216,0.0004919246],"genre_scores_gemma":[0.00083632657,0.9818176,0.000033231907,0.0034016075,0.002528298,0.0013453483,0.00009705704,0.00029738373,0.0096431505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950051,0.00058924453,0.0013178068,0.0010917508,0.0009131516,0.0010830023],"domain_scores_gemma":[0.99644685,0.0004587909,0.0007775944,0.0016287438,0.00036426642,0.0003237601],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0015060086,0.0011133829,0.0028381574,0.0003399605,0.00032016425,0.00013019309,0.0009976977,0.0005951751,0.0064256294],"category_scores_gemma":[0.000048829857,0.0006677328,0.0013972297,0.0009428874,0.0002183715,0.0001730868,0.00028826998,0.0012390987,0.00032398102],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082718255,0.000098399716,0.00015835113,0.006647615,0.0016854492,0.000032345983,0.0004308575,0.000006638724,0.0002373214,0.000008852787,0.031185888,0.9512364],"study_design_scores_gemma":[0.0016423394,0.0001013397,0.002209356,0.040737204,0.0018618391,0.0010751217,0.0001243729,0.0000046166124,0.000008780255,0.0000031943594,0.9514269,0.00080489763],"about_ca_topic_score_codex":0.0060931956,"about_ca_topic_score_gemma":0.0002407547,"teacher_disagreement_score":0.9504316,"about_ca_system_score_codex":0.0021432212,"about_ca_system_score_gemma":0.0029611941,"threshold_uncertainty_score":0.9995774},"labels":[],"label_agreement":null},{"id":"W2985910591","doi":"10.1038/s41523-019-0138-2","title":"Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"National Institute for Health and Care Research; Breast Cancer Research Foundation","keywords":"Menstrual cycle; Breast cancer; Endocrinology; Internal medicine; Progesterone receptor; Gene expression; Estrogen; Hormone; Cancer; Hormone receptor; Medicine; Biology; Estrogen receptor; Gene; Genetics","score_opus":0.0028448944971422234,"score_gpt":0.22628770040756366,"score_spread":0.22344280591042143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985910591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307793,0.004009268,0.0000012447499,0.0007953726,0.00038269057,0.0004890894,0.00082508096,0.000027933836,0.00039140467],"genre_scores_gemma":[0.9967373,0.0018556871,0.00003624434,0.00018346033,0.00017568519,0.0001593894,0.00034540944,0.00006207642,0.0004447583],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9980845,0.00017218932,0.00029431598,0.0006269186,0.0002304232,0.0005916765],"domain_scores_gemma":[0.99930024,0.000014317322,0.00016907154,0.0002744277,0.00009963588,0.0001423284],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018617796,0.00032267242,0.00034522158,0.00012236784,0.000052776788,0.000022130134,0.00021044379,0.00059328263,0.00032300956],"category_scores_gemma":[0.0000089256055,0.0002933996,0.00009943576,0.0003133744,0.00006674912,0.000016736878,0.00013111078,0.00036824384,0.00004761059],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059246307,0.0001571305,0.11346485,0.0000102021495,0.00012667962,0.000013564981,0.00015096419,0.0004887313,0.8800839,0.000003387064,0.0005498725,0.004358214],"study_design_scores_gemma":[0.0044588675,0.0002215704,0.5318968,0.0003629458,0.000040879837,0.00008973906,0.00010785115,0.0002906117,0.46170974,0.000013247045,0.00021070575,0.00059703604],"about_ca_topic_score_codex":0.0012805274,"about_ca_topic_score_gemma":0.0005075699,"teacher_disagreement_score":0.41843197,"about_ca_system_score_codex":0.0002879343,"about_ca_system_score_gemma":0.00018509263,"threshold_uncertainty_score":0.99995184},"labels":[],"label_agreement":null},{"id":"W2989510802","doi":"10.1038/s41523-019-0127-5","title":"The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer","year":2019,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of British Columbia; University of Toronto; Royal Victoria Hospital; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Université Laval; BC Cancer Agency; Centre hospitalier universitaire de Québec; McGill University; Queen's University","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; NIH Office of the Director; Servicio Gallego de Salud; National Cancer Institute; European Regional Development Fund; Cancer Council Victoria; Medical Research Council; European Commission; Lietuvos Mokslo Taryba; Canadian Institutes of Health Research; Imperial Experimental Cancer Medicine Centre; Division of Cancer Prevention, National Cancer Institute; National Institutes of Health; Freistaat Sachsen; Centro de Investigación Biomédica en Red de Cáncer; Federal Agency for Scientific Organizations; National Institute of General Medical Sciences; Deutschen Konsortium für Translationale Krebsforschung; KWF Kankerbestrijding; Fox Chase Cancer Center; Ministero dello Sviluppo Economico; Jewish General Hospital; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Memorial Sloan-Kettering Cancer Center; Istituto Oncologico Veneto; Institut National Du Cancer; National Health and Medical Research Council; Deutsche Krebshilfe; Fondazione Umberto Veronesi; Vetenskapsrådet; Stockholms Läns Landsting; Kuopion Yliopistollinen Sairaala; Ministero della Salute; McGill University; Generalitat de Catalunya; Cancer Center, University of Kansas; University of Southern California; Cancerfonden; Landspítali Háskólasjúkrahús; Ministerio de Economía y Competitividad; National Center for Advancing Translational Sciences; Bundesministerium für Bildung und Forschung; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Fondation ARC pour la Recherche sur le Cancer; American Cancer Society; Cancer Australia; Russian Foundation for Basic Research; Deutsche Gesetzliche Unfallversicherung; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Deutsche Forschungsgemeinschaft; Deutscher Akademischer Austauschdienst; Programme Grants for Applied Research; Robert Bosch Stiftung; Associazione Italiana per la Ricerca sul Cancro; Karolinska Institutet; Hungarian Scientific Research Fund; Harvard T.H. Chan School of Public Health; Cancer Association of South Africa; Royal Marsden NHS Foundation Trust; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya; University of Cambridge; Nemzeti Kutatási Fejlesztési és Innovációs Hivatal; Government of Canada; Georgetown University; Breast Cancer Campaign; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Breast Cancer Foundation; National Institute of Environmental Health Sciences; Swedish Cancer Foundation; McGill University Health Centre; University of California, Irvine; David F. and Margaret T. Grohne Family Foundation; Deutsches Krebsforschungszentrum; World Cancer Research Fund; Helsingin ja Uudenmaan Sairaanhoitopiiri; Lon V. Smith Foundation; Ministère du Développement Économique, de l’Innovation et de l’Exportation; Fundación Mutua Madrileña; Breast Cancer Research Foundation; University of Chicago; NRG Oncology; Fondation du cancer du sein du Québec; Universitätsklinikum Hamburg-Eppendorf; Dr. Ralph and Marian Falk Medical Research Trust; Kansas Bioscience Authority; Institut Català de la Salut; University of Pennsylvania; Liga Portuguesa Contra o Cancro; University College London; Cancer Research UK; Beckman Research Institute, City of Hope; Susan G. Komen for the Cure; Beth Israel Deaconess Medical Center; Genome Canada; Brigham and Women's Hospital; Instituto de Salud Carlos III; Ohio State University; University of California, San Francisco; U.S. Department of Health and Human Services; Rheinische Friedrich-Wilhelms-Universität Bonn; Oak Foundation; Fisher Center for Alzheimer's Research Foundation; Fanconi Anemia Research Fund; Fonds Wetenschappelijk Onderzoek","keywords":"CHEK2; Breast cancer; PALB2; Triple-negative breast cancer; Biology; Cancer; Olaparib; Cancer research; Genetics; Internal medicine; Oncology; Medicine; Germline mutation; Mutation; Gene","score_opus":0.00440340564138385,"score_gpt":0.22794918483638513,"score_spread":0.22354577919500127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989510802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99345404,0.0006163624,0.00013584322,0.0006978391,0.0005092007,0.00054935855,0.0025386042,0.000028864792,0.001469899],"genre_scores_gemma":[0.99578273,0.00040862476,0.00013569473,0.00029813222,0.00020914846,0.00015043549,0.000028412494,0.000054300803,0.0029324924],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99834484,0.00014363059,0.00028415557,0.00048302408,0.00032788023,0.00041647567],"domain_scores_gemma":[0.99844736,0.000051988212,0.00048002505,0.0005284992,0.00040246363,0.00008964185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033860366,0.00025708336,0.00029187772,0.000027202079,0.00015488488,0.000030861534,0.00031788406,0.00017785042,0.00040807287],"category_scores_gemma":[0.00005546727,0.00017149492,0.00013522495,0.00020568252,0.00011526959,0.000010394508,0.00010501818,0.00019276427,0.000011063766],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00399086,0.00044886387,0.28347227,0.00012863989,0.0050185537,0.000014341426,0.0015479362,0.0008550028,0.6111933,0.0005124898,0.007898851,0.0849189],"study_design_scores_gemma":[0.0069054305,0.0005617731,0.66086483,0.0005639035,0.00053910475,0.00019874038,0.00081705896,0.0019740693,0.3222407,0.0004022138,0.0038141843,0.0011179738],"about_ca_topic_score_codex":0.0025352675,"about_ca_topic_score_gemma":0.0015231294,"teacher_disagreement_score":0.37739253,"about_ca_system_score_codex":0.00011855415,"about_ca_system_score_gemma":0.00041305384,"threshold_uncertainty_score":0.699336},"labels":[],"label_agreement":null},{"id":"W2990245076","doi":"10.1038/s41523-019-0140-8","title":"Publisher Correction: Homologous recombination DNA repair defects in PALB2-associated breast cancers","year":2019,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; McGill Genome Centre; Jewish General Hospital","funders":"Breast Cancer Research Foundation","keywords":"PALB2; Homologous recombination; Homologous chromosome; DNA repair; Genetics; Recombination; DNA; Breast cancer; Biology; Cancer; Gene; Mutation; Germline mutation","score_opus":0.0057702605526329795,"score_gpt":0.22862949549268266,"score_spread":0.2228592349400497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990245076","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14544085,0.012529289,0.00006982672,0.002213649,0.6245341,0.004368485,0.0022790905,0.0011407065,0.20742403],"genre_scores_gemma":[0.2895012,0.0021413383,0.000047231475,0.0013007075,0.0035980702,0.0009346597,0.006664708,0.0004080988,0.695404],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644846,0.00028145598,0.0005486064,0.0013994783,0.0005046492,0.0008173663],"domain_scores_gemma":[0.9978034,0.000021020336,0.0005502786,0.00092393527,0.00052719243,0.0001741756],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00045834846,0.0006621921,0.00069029006,0.00028690445,0.00010466794,0.00010510049,0.0005024277,0.002003075,0.0005639866],"category_scores_gemma":[0.00013007551,0.0007208878,0.00044087245,0.0005093347,0.00009141574,0.000030079647,0.00023472334,0.00101619,0.00005461881],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002015798,0.0001495347,0.0063364552,0.00010685814,0.00029221887,0.000025281353,0.00003518269,0.000104615174,0.0015748881,0.000007365573,0.9849813,0.006184714],"study_design_scores_gemma":[0.006918259,0.0010931746,0.22739099,0.0025451318,0.0006075425,0.0015478914,0.00026079325,0.0014055938,0.002344996,0.0004128652,0.75097454,0.0044982512],"about_ca_topic_score_codex":0.004535948,"about_ca_topic_score_gemma":0.013591609,"teacher_disagreement_score":0.62093604,"about_ca_system_score_codex":0.0019324963,"about_ca_system_score_gemma":0.002075821,"threshold_uncertainty_score":0.99952424},"labels":[],"label_agreement":null},{"id":"W3007147204","doi":"10.1038/s41523-020-0149-z","title":"The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Niagara Health System; Centre Hospitalier de l’Université de Montréal; McMaster University; Ontario Clinical Oncology Group; Juravinski Hospital; Juravinski Cancer Centre; Nova Scotia Health Authority; Ottawa Regional Cancer Foundation; Capital District Health Authority; Ottawa Hospital; University of Ottawa; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Dalhousie University; University of Toronto","funders":"","keywords":"Medicine; Weight loss; Randomized controlled trial; Hazard ratio; Body mass index; Breast cancer; Overweight; Obesity; Internal medicine; Confidence interval; Letrozole; Cancer; Oncology; Physical therapy; Tamoxifen","score_opus":0.012963330855708801,"score_gpt":0.3019813143102549,"score_spread":0.2890179834545461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007147204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95366275,0.0045369505,0.000052657044,0.036510836,0.0014897352,0.00213214,0.00076414447,0.000058549056,0.00079224695],"genre_scores_gemma":[0.99442333,0.0027798873,0.000008373722,0.00071386463,0.0012913911,0.0004510459,0.000015558842,0.000032026273,0.0002845105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99824375,0.00014168111,0.00062785426,0.00030361005,0.00038388322,0.00029924215],"domain_scores_gemma":[0.99908155,0.000115357536,0.0002701328,0.00021594208,0.0001504341,0.00016659693],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00038004233,0.0002075649,0.0007629159,0.00006256583,0.000051408315,0.000022678536,0.00014923936,0.00009831495,0.0020796512],"category_scores_gemma":[0.00004286996,0.00012884197,0.0003050757,0.0002993151,0.00022559169,0.000098357275,0.000057103047,0.00028577208,0.000008628358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8757947,0.00021804278,0.023676869,0.00010995193,0.00028671965,0.000014171543,0.0005631899,0.000013566039,0.00049057725,0.0000971939,0.0015575559,0.09717747],"study_design_scores_gemma":[0.8931197,0.00029350768,0.09846123,0.0004850972,0.00037518525,0.00006526186,0.0001215398,0.00039652773,0.00026696423,0.000049893908,0.006160259,0.00020484877],"about_ca_topic_score_codex":0.014301654,"about_ca_topic_score_gemma":0.0017530002,"teacher_disagreement_score":0.09697262,"about_ca_system_score_codex":0.00028739971,"about_ca_system_score_gemma":0.00031116322,"threshold_uncertainty_score":0.9988326},"labels":[],"label_agreement":null},{"id":"W3008259997","doi":"10.1038/s41523-020-0148-0","title":"The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Epirubicin; Cyclophosphamide; Internal medicine; Oncology; Anthracycline; Hazard ratio; Breast cancer; Chemotherapy; Adjuvant chemotherapy; Fluorouracil; Clinical endpoint; Proportional hazards model; Adjuvant; Methotrexate; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.006323787954146343,"score_gpt":0.2503081837815237,"score_spread":0.24398439582737735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008259997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721047,0.0022971043,0.00005700024,0.021028174,0.00023250494,0.0008729059,0.0033633485,0.000026714613,0.00001751874],"genre_scores_gemma":[0.9936405,0.0013844598,0.00015882775,0.0030563741,0.00048791408,0.0010787464,0.00008681735,0.00006511561,0.000041272702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981129,0.00012526877,0.00030105526,0.00073466264,0.0002524837,0.00047361397],"domain_scores_gemma":[0.99903035,0.00003748917,0.00016164909,0.00031858278,0.00024623363,0.00020568061],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000115797346,0.00035524234,0.0003314429,0.00004118316,0.00024615598,0.00004521898,0.00024222935,0.0001223839,0.000068285764],"category_scores_gemma":[0.000032129996,0.00026105403,0.000071628645,0.0002532731,0.00016734011,0.000011114146,0.00014548891,0.0001439317,0.00000718896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009250366,0.00026091686,0.82949334,0.000054990145,0.00018971134,0.0000043954815,0.0003189212,0.00036198832,0.036782496,0.0000040665786,0.0019464778,0.12133231],"study_design_scores_gemma":[0.004262018,0.0001871279,0.9451895,0.0000742699,0.000051139577,0.00000537152,0.000057209993,0.00006349866,0.04613006,0.000006838528,0.0036347844,0.000338231],"about_ca_topic_score_codex":0.0025524923,"about_ca_topic_score_gemma":0.0012946825,"teacher_disagreement_score":0.120994076,"about_ca_system_score_codex":0.00014741717,"about_ca_system_score_gemma":0.0003110144,"threshold_uncertainty_score":0.99998415},"labels":[],"label_agreement":null},{"id":"W3016939709","doi":"10.1038/s41523-020-0156-0","title":"Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":206,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of British Columbia; Spinal Cord Injury BC; National Circus School; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; BC Cancer Agency","funders":"National Center for Research Resources; Daiichi Sankyo Europe; National Cancer Institute; Medical Research Council; Stand Up To Cancer; National Institutes of Health; Rosetrees Trust; CRUK Lung Cancer Centre of Excellence; National Institute for Health and Care Research; University College London; Wellcome Trust; Cancer Research UK; Wallace H. Coulter Foundation; Myriad Genetics; Francis Crick Institute; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Prostate Cancer Foundation; AstraZeneca; U.S. Department of Defense; Eli Lilly and Company; Case Western Reserve University; National Breast Cancer Foundation; U.S. Department of Veterans Affairs; Breast Cancer Alliance; Pfizer; Amgen; European Commission; DOD Peer Reviewed Cancer Research Program; Breast Cancer Research Foundation","keywords":"Breast cancer; Cancer; Medicine; Stromal cell; Breast tumor; Pathology; Stromal tumor; Oncology; Internal medicine","score_opus":0.019980693724880205,"score_gpt":0.30127865816730337,"score_spread":0.28129796444242317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016939709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98052835,0.00259635,0.000015137271,0.014800579,0.0003033063,0.00038203155,0.00023880674,0.00008463246,0.0010507787],"genre_scores_gemma":[0.99167573,0.00035328642,0.00019167975,0.006733452,0.00078629423,0.00014559503,0.000014204727,0.000056524095,0.000043237425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978503,0.00007005092,0.0005677193,0.0005329175,0.00039198334,0.0005870298],"domain_scores_gemma":[0.99925524,0.00005330696,0.000177571,0.00020845809,0.000092491304,0.0002129333],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00020048936,0.0003163875,0.00054736,0.00015947691,0.00006439595,0.00008641547,0.0001706511,0.000117692056,0.002001315],"category_scores_gemma":[0.000020325224,0.00029029328,0.00012522943,0.00078982225,0.00011439471,0.00037752936,0.0000513493,0.00037790416,0.000010944357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028252965,0.00013014874,0.82614374,0.00023599296,0.00008862274,0.00018645858,0.00076593,0.00019904305,0.082567595,0.000009245428,0.0006150115,0.08623292],"study_design_scores_gemma":[0.006242288,0.00005682341,0.9856553,0.0014383584,0.000044803473,0.0003442893,0.0006089952,0.0022903169,0.0020622306,0.0000052145588,0.0009021535,0.00034923598],"about_ca_topic_score_codex":0.014642091,"about_ca_topic_score_gemma":0.0017240283,"teacher_disagreement_score":0.15951155,"about_ca_system_score_codex":0.0011660904,"about_ca_system_score_gemma":0.0013017614,"threshold_uncertainty_score":0.99995494},"labels":[],"label_agreement":null},{"id":"W3025373602","doi":"10.1038/s41523-020-0155-1","title":"Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; BC Cancer Agency; Princess Margaret Cancer Centre; University of Ottawa; Ontario Institute for Cancer Research; Centre for Advancing Health Outcomes; Translational Research in Oncology; University of British Columbia","funders":"Medical Research Council; KWF Kankerbestrijding; National Institute for Health and Care Research; Francis Crick Institute; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Clinical trial; Biomarker; Medicine; Immunotherapy; Workflow; Risk stratification; Oncology; Medical physics; Internal medicine; Computer science; Cancer; Database; Biology","score_opus":0.10303037676895636,"score_gpt":0.46580781256314774,"score_spread":0.36277743579419136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025373602","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011189948,0.98249584,0.012234852,0.000092549104,0.0003386337,0.003495631,0.001112368,0.000021251357,0.00009699809],"genre_scores_gemma":[0.0018620449,0.98776656,0.008146328,0.00007159451,0.00071482244,0.0012298793,0.00015863741,0.000043705986,0.000006441428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961633,0.00039805254,0.0025986657,0.00041706619,0.0002539081,0.00016897448],"domain_scores_gemma":[0.995525,0.0013038131,0.0026492777,0.00033946297,0.000120457575,0.00006199652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022913718,0.00028298804,0.0028601948,0.00016519055,0.000020953026,0.000009316094,0.00016428715,0.00029148557,0.00007436064],"category_scores_gemma":[0.00057554734,0.0002121812,0.0010407037,0.00046031253,0.00008892884,0.000037056896,0.000027454746,0.00032404708,0.0000014025909],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021069038,0.00011768957,0.00059065426,0.011012288,0.0006558476,0.000001379605,0.00005473712,0.000001020681,0.000011634529,0.00046031494,0.0000791694,0.98490834],"study_design_scores_gemma":[0.011454434,0.00086570345,0.0118418,0.12913495,0.009841683,0.00006643066,0.00042227173,0.00085050776,0.00013392516,0.00076140574,0.8338316,0.0007952908],"about_ca_topic_score_codex":0.0005076805,"about_ca_topic_score_gemma":0.00005363739,"teacher_disagreement_score":0.9841131,"about_ca_system_score_codex":0.00038792656,"about_ca_system_score_gemma":0.0006212572,"threshold_uncertainty_score":0.8652498},"labels":[],"label_agreement":null},{"id":"W3025630280","doi":"10.1038/s41523-020-0154-2","title":"Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group","year":2020,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Université Laval; Translational Research in Oncology; University of British Columbia; Spinal Cord Injury BC; BC Cancer Agency; Ontario Institute for Cancer Research","funders":"National Center for Research Resources; Genentech; National Institute for Health and Care Research; Cancer Research UK; Puma Biotechnology; Georgia Clinical and Translational Science Alliance; Susan G. Komen; Daiichi Sankyo Europe; National Cancer Institute; Case Western Reserve University; G1 Therapeutics; Celgene; Eli Lilly and Company; U.S. Department of Defense; DOD Peer Reviewed Cancer Research Program; Leidos; Breast Cancer Research Foundation; Sanofi; AstraZeneca; U.S. Department of Veterans Affairs; National Institutes of Health; U.S. Department of Health and Human Services; Breast Cancer Alliance; Wallace H. Coulter Foundation; Pfizer; Amgen","keywords":"Biomarker; Oncology; Internal medicine; Medicine; Biology; Genetics","score_opus":0.03036765664404596,"score_gpt":0.34704187538045944,"score_spread":0.3166742187364135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025630280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048058425,0.9925802,0.00044356156,0.0005343265,0.0017009599,0.0004069585,0.0019369401,0.000010045735,0.001906472],"genre_scores_gemma":[0.007913376,0.9844298,0.0013280067,0.0009221614,0.0019374316,0.00021609338,0.0031755758,0.00005838278,0.00001921094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983138,0.00008761341,0.00066011376,0.00050258974,0.00026610555,0.00016982165],"domain_scores_gemma":[0.99836475,0.00029396545,0.0008367001,0.00032620918,0.00012137966,0.000056994693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020252803,0.00028954344,0.0006248724,0.000036516834,0.00007185921,0.000051838935,0.00047057585,0.0001777683,0.00013688585],"category_scores_gemma":[0.00007719479,0.00022169962,0.0003210518,0.00010029397,0.00009447706,0.000002573076,0.00027483513,0.00017755396,0.0000029992218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006957224,0.00008124585,0.00178713,0.0002011857,0.0009774945,0.00006120806,0.000014208442,0.00027468902,0.00029772054,0.0001538049,0.0042328644,0.9918489],"study_design_scores_gemma":[0.00036965203,0.000058094025,0.0027087734,0.0015317786,0.00022001353,0.00025971982,0.000013718124,0.00020358487,0.000019689509,0.00003053253,0.99435264,0.00023179236],"about_ca_topic_score_codex":0.00043671022,"about_ca_topic_score_gemma":0.00011617509,"teacher_disagreement_score":0.9916171,"about_ca_system_score_codex":0.00041890919,"about_ca_system_score_gemma":0.0019318865,"threshold_uncertainty_score":0.9040648},"labels":[],"label_agreement":null},{"id":"W3034928696","doi":"10.1038/s41523-020-0166-y","title":"Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Women's College Hospital; Statistics Canada; University of Toronto","funders":"Sanofi; GlaxoSmithKline; Servier; Breast Cancer Research Foundation; Pfizer; Genentech; Mersana Therapeutics; PTC Therapeutics; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Letrozole; Estrone; Medicine; Internal medicine; Leptin; Endocrinology; Estrogen; Body mass index; Vitamin D and neurology; Tamoxifen; Obesity; Breast cancer; Cancer","score_opus":0.029887952668226164,"score_gpt":0.31046283682795656,"score_spread":0.2805748841597304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034928696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971592,0.0002564574,0.000015078566,0.0011767655,0.000067335095,0.0008167555,0.00040492133,0.0000418504,0.000061626975],"genre_scores_gemma":[0.9988868,0.000020220828,0.00003934761,0.00036624738,0.0005029554,0.00009376461,0.00000655016,0.00003060788,0.000053484906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986415,0.000045523397,0.00025305196,0.00037051542,0.00033623187,0.0003531922],"domain_scores_gemma":[0.99943215,0.00002917295,0.00012799521,0.00010305906,0.00008870263,0.00021891289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016684325,0.0001783864,0.00045694722,0.000072452945,0.000050508173,0.000029014192,0.000050429342,0.000081487975,0.00018835338],"category_scores_gemma":[0.000030121671,0.0001629544,0.000028117038,0.0002954835,0.00002469774,0.00012924992,0.000057508914,0.00026294106,0.0000047069225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002731097,0.00011193451,0.9803932,0.000029716188,0.00025934534,0.000022960896,0.004435833,0.0000099625695,0.001863975,0.0000016321961,0.000038669616,0.012559664],"study_design_scores_gemma":[0.0037282538,0.0005280381,0.99336463,0.000054179392,0.00018542822,0.000011822315,0.0015373796,0.00010255583,0.00014153024,0.000009479845,0.00017470321,0.00016197226],"about_ca_topic_score_codex":0.0031301314,"about_ca_topic_score_gemma":0.00025629345,"teacher_disagreement_score":0.012971461,"about_ca_system_score_codex":0.0020508503,"about_ca_system_score_gemma":0.00024960138,"threshold_uncertainty_score":0.66450876},"labels":[],"label_agreement":null},{"id":"W3043321283","doi":"10.1038/s41523-020-0171-1","title":"Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cure Brain Cancer Foundation","keywords":"Cyclophosphamide; Medicine; Metastatic breast cancer; Regimen; Breast cancer; Cancer; CD8; Immune system; Primary tumor; Oncology; Combination therapy; Cancer research; Concomitant; Blockade; Immunotherapy; Mammary tumor; Chemotherapy; Internal medicine; Immunology; Metastasis; Receptor","score_opus":0.01242845385308866,"score_gpt":0.26374376268641,"score_spread":0.2513153088333213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043321283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217166,0.018259937,0.000012539711,0.008133916,0.00019989362,0.0006281873,0.00031551355,0.00006191431,0.00021640435],"genre_scores_gemma":[0.98976976,0.0039872103,0.00017371029,0.005528407,0.00020522032,0.00013322357,0.000022109345,0.00005853544,0.0001218126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825305,0.00006114502,0.00045333535,0.000580478,0.00023661666,0.00041539923],"domain_scores_gemma":[0.9991873,0.0000640025,0.00017317322,0.0002588497,0.00007135269,0.0002453178],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017857298,0.0003378873,0.00071684807,0.00012939051,0.00007588958,0.000041040177,0.000101417805,0.00006936237,0.0008007066],"category_scores_gemma":[0.000009787885,0.00029893903,0.00009365856,0.00035041032,0.0002070477,0.00021559121,0.00008379583,0.00029561136,0.000004338356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005015703,0.00024388195,0.86280537,0.0009226791,0.0007852192,0.0002361986,0.00044743824,0.0000621093,0.06371783,0.00001503695,0.0007320136,0.06501651],"study_design_scores_gemma":[0.007351753,0.0000817441,0.98764735,0.0003823431,0.0002400546,0.0004314886,0.00010435143,0.00032840818,0.00080226053,0.0000054641164,0.0023020639,0.00032270557],"about_ca_topic_score_codex":0.0039989874,"about_ca_topic_score_gemma":0.00019320578,"teacher_disagreement_score":0.12484198,"about_ca_system_score_codex":0.00042774758,"about_ca_system_score_gemma":0.00053092075,"threshold_uncertainty_score":0.9999463},"labels":[],"label_agreement":null},{"id":"W3048442532","doi":"10.1038/s41523-020-00177-6","title":"Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; NODAL; Disease; Cancer","score_opus":0.010404536266655875,"score_gpt":0.2591173577331325,"score_spread":0.2487128214664766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048442532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8963996,0.029852696,0.00046461684,0.03061057,0.00043432496,0.002304461,0.03977534,0.00007277317,0.00008559941],"genre_scores_gemma":[0.98930717,0.0032300309,0.00028532837,0.0016740331,0.0018467967,0.0031320325,0.0003322631,0.000090766975,0.00010160087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786764,0.00006803086,0.00036621344,0.00084380916,0.00030144857,0.00055285153],"domain_scores_gemma":[0.9986246,0.0000407694,0.00021475754,0.00033554592,0.00046045956,0.00032385523],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000053717165,0.00045164127,0.00045281783,0.000035976183,0.00011134842,0.000023845481,0.00025652137,0.00009741626,0.00024994285],"category_scores_gemma":[0.000027471668,0.0003918631,0.00022424429,0.00017447432,0.0002673666,0.0000186724,0.00013192145,0.000116402385,0.0000068972718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06936897,0.0010186933,0.47283933,0.00039958314,0.0024321973,0.00004511082,0.00097052817,0.00038207782,0.3271598,0.000048726175,0.026599512,0.09873548],"study_design_scores_gemma":[0.0044397255,0.0004066065,0.9500675,0.00014377123,0.00026073065,0.000021021087,0.0000942608,0.000031505388,0.037883066,0.000020845982,0.0060450057,0.0005859525],"about_ca_topic_score_codex":0.00061436434,"about_ca_topic_score_gemma":0.00009895587,"teacher_disagreement_score":0.47722816,"about_ca_system_score_codex":0.000107703636,"about_ca_system_score_gemma":0.00045014746,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W3083798800","doi":"10.1038/s41523-020-00185-6","title":"Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer","year":2020,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; McGill University; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute; Medical Research Council; Canadian Institutes of Health Research; Associazione Italiana per la Ricerca sul Cancro; Odense Universitetshospital; Fondation du cancer du sein du Québec; Génome Québec; Genome Canada; National Institutes of Health; National Health and Medical Research Council; Cancer Research UK; Government of Canada; Deutsche Krebshilfe; Breast Cancer Research Foundation","keywords":"Germline; Breast cancer; Germline mutation; Oncology; Genetics; Variation (astronomy); Biology; Medicine; Internal medicine; Cancer; Mutation; Gene","score_opus":0.005966913367636,"score_gpt":0.2273153082776421,"score_spread":0.2213483949100061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083798800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884945,0.0004476174,0.0009960576,0.008443796,0.000086918,0.00022262373,0.0012114324,0.0000080501195,0.00008901645],"genre_scores_gemma":[0.9985421,0.0002630146,0.00016442643,0.00041617718,0.0003422591,0.00011852148,0.000025537889,0.000027878366,0.00010012101],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99894863,0.000076974844,0.0001903529,0.00029434817,0.00026964655,0.00022003055],"domain_scores_gemma":[0.9989866,0.000018513601,0.0003346664,0.00019670285,0.00038771683,0.000075775344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002187559,0.00014430482,0.0002074598,0.000019809419,0.000052427036,0.0000133278445,0.00013245069,0.000099012876,0.0001704898],"category_scores_gemma":[0.000011812342,0.0000994314,0.000026673388,0.00022189326,0.00010160952,0.000010937374,0.00005083287,0.000085464926,5.361909e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003847724,0.00013946323,0.30140746,0.00022847898,0.0019341721,0.0000022027234,0.003547242,0.005011989,0.6537675,0.00009188828,0.0016638649,0.028358027],"study_design_scores_gemma":[0.0016238346,0.00019637498,0.989678,0.000036714086,0.00016431347,0.000023687793,0.00024069904,0.00025202855,0.006410644,0.000010432959,0.0011756468,0.00018757934],"about_ca_topic_score_codex":0.00042718882,"about_ca_topic_score_gemma":0.00055991765,"teacher_disagreement_score":0.68827057,"about_ca_system_score_codex":0.00022260653,"about_ca_system_score_gemma":0.00053963513,"threshold_uncertainty_score":0.40546948},"labels":[],"label_agreement":null},{"id":"W3128758614","doi":"10.1038/s41523-021-00222-y","title":"Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"European Organisation for Research and Treatment of Cancer; University of Nottingham; National Institute for Health and Care Research; Cancer Research UK; AstraZeneca","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Endocrine system; Internal medicine; Hormone; Hormone receptor; Cancer; Endocrinology","score_opus":0.06251399066135013,"score_gpt":0.36516630094651714,"score_spread":0.30265231028516704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128758614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74400705,0.1751973,0.001821964,0.03315531,0.0017728184,0.0026799021,0.038073014,0.0006000972,0.0026925593],"genre_scores_gemma":[0.9857139,0.0041149515,0.0016719669,0.0012531747,0.00065343257,0.00089992746,0.00051587966,0.0002509452,0.004925836],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9955514,0.00025234214,0.0010378492,0.0011358225,0.0010271792,0.0009953725],"domain_scores_gemma":[0.9964921,0.00020106179,0.0006247841,0.00088395865,0.0013557753,0.00044234542],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016174302,0.00095064373,0.002503944,0.00025820482,0.00017956624,0.00006260722,0.00030131455,0.0001469837,0.012435566],"category_scores_gemma":[0.000017761113,0.00075744296,0.0010474471,0.0010984531,0.0004868236,0.0004995615,0.00011884111,0.00050963816,0.000036294303],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02496611,0.0013710344,0.005493799,0.00033121946,0.084310815,0.0002301357,0.001100582,0.0007383855,0.79407954,0.00007223996,0.006992655,0.08031347],"study_design_scores_gemma":[0.041563574,0.0010974364,0.16372077,0.0007034816,0.05548643,0.0019737321,0.0014622281,0.0005103799,0.71936333,0.00011696352,0.01146629,0.0025354158],"about_ca_topic_score_codex":0.010533616,"about_ca_topic_score_gemma":0.00040689166,"teacher_disagreement_score":0.24170685,"about_ca_system_score_codex":0.0009191453,"about_ca_system_score_gemma":0.0007737121,"threshold_uncertainty_score":0.99948764},"labels":[],"label_agreement":null},{"id":"W3132376902","doi":"10.1038/s41523-021-00220-0","title":"Dual- versus single-agent HER2 inhibition and incidence of intracranial metastatic disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Cancer Care Ontario; University of Toronto","funders":"University of Toronto","keywords":"Trastuzumab; Medicine; Internal medicine; Oncology; Incidence (geometry); Breast cancer; Meta-analysis; Randomized controlled trial; Targeted therapy; Observational study; Metastatic breast cancer; Surgery; Cancer","score_opus":0.16813124575614494,"score_gpt":0.43838207818789926,"score_spread":0.2702508324317543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132376902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010040268,0.9935162,0.000030989868,0.0009572845,0.00007775764,0.0036354063,0.0017143503,0.000022629374,0.000035362664],"genre_scores_gemma":[0.00022478017,0.99658966,0.00018957183,0.00026775757,0.000092300405,0.0021272555,0.00019530926,0.00007327196,0.00024007645],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99485403,0.0010528931,0.0015824703,0.00088012376,0.0012347111,0.00039576544],"domain_scores_gemma":[0.99657327,0.00050850434,0.0008775915,0.00093580835,0.00057884236,0.00052600814],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012358571,0.0006138219,0.010033371,0.00039643535,0.000062926345,0.0000698871,0.00013053665,0.00012161322,0.0025828131],"category_scores_gemma":[0.0005963487,0.00042413085,0.00174417,0.0015730619,0.00024144487,0.00011640549,0.00020621844,0.00049106457,0.000011387462],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041469902,0.000099931625,0.0000038937956,0.88933796,0.0921531,0.000404914,0.00002469499,5.6462903e-7,5.685745e-7,0.000014674967,0.00019376185,0.017724486],"study_design_scores_gemma":[0.0003576453,0.000068214,0.000015987704,0.19124672,0.8013568,0.0005536755,0.000016465669,0.0000096422955,5.735229e-7,0.0000028311044,0.0060934345,0.000278014],"about_ca_topic_score_codex":0.00036012277,"about_ca_topic_score_gemma":0.00018653856,"teacher_disagreement_score":0.70920366,"about_ca_system_score_codex":0.0006063011,"about_ca_system_score_gemma":0.0012853162,"threshold_uncertainty_score":0.99982107},"labels":[],"label_agreement":null},{"id":"W3135423629","doi":"10.1038/s41523-021-00226-8","title":"Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Botwinick-Wolfensohn Foundation; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation; National Cancer Institute; National Institutes of Health; Conquer Cancer Foundation; U.S. Department of Health and Human Services","keywords":"Breast cancer; Aromatase; Medicine; Internal medicine; Endocrinology; Leptin; Body mass index; Adiponectin; Adipose tissue; Obesity; Cancer; Oncology; Insulin resistance","score_opus":0.006200436157666598,"score_gpt":0.25066690108648804,"score_spread":0.24446646492882143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135423629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982003,0.00062808336,0.000039050043,0.00032510053,0.00007986537,0.0004038909,0.00024377494,0.000027988715,0.000051943385],"genre_scores_gemma":[0.9991342,0.00024355178,0.000061659404,0.00007762258,0.00010818526,0.00017554188,0.000032207514,0.00001974825,0.00014731463],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9989868,0.000058097376,0.0002304609,0.0002755172,0.0002558252,0.00019330696],"domain_scores_gemma":[0.9993463,0.00007889171,0.0001253749,0.00020614378,0.000111817564,0.00013143916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008940234,0.00014979579,0.00038242128,0.00010491842,0.000040508723,0.000015128903,0.00003557643,0.00006896542,0.00020529675],"category_scores_gemma":[0.000019575898,0.00010357938,0.000026523927,0.00027122832,0.000043267806,0.00011970598,0.000022954473,0.00012987401,0.0000031808518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011864787,0.0008151773,0.36696237,0.005457407,0.0003385369,0.00064942666,0.0052301865,0.000411579,0.45495155,0.00005793939,0.00036880161,0.15289225],"study_design_scores_gemma":[0.0040515014,0.00011804613,0.95484865,0.0029005336,0.00010965932,0.0008418284,0.00044027573,0.00005847758,0.03637876,0.000011333629,0.000105385756,0.00013554984],"about_ca_topic_score_codex":0.00090600824,"about_ca_topic_score_gemma":0.0005470854,"teacher_disagreement_score":0.5878863,"about_ca_system_score_codex":0.00037127084,"about_ca_system_score_gemma":0.00032081796,"threshold_uncertainty_score":0.42238447},"labels":[],"label_agreement":null},{"id":"W3136326764","doi":"10.1038/s41523-021-00238-4","title":"Co-dependency for MET and FGFR1 in basal triple-negative breast cancers","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Genome Canada; Canadian Institutes of Health Research; Deutsches Krebsforschungszentrum; Genentech; McGill University","keywords":"Triple-negative breast cancer; Cancer research; Fibroblast growth factor receptor 1; Breast cancer; Basal (medicine); Carcinogenesis; Medicine; Biology; Cancer; Oncology; Internal medicine; Receptor; Fibroblast growth factor","score_opus":0.01924902441114627,"score_gpt":0.32035437160245767,"score_spread":0.3011053471913114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136326764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92952126,0.017297657,0.0005681774,0.01896064,0.0025101486,0.0031189548,0.011277729,0.00015311046,0.016592337],"genre_scores_gemma":[0.9904453,0.0019427765,0.0012870714,0.0019326006,0.00070160785,0.00046190817,0.000077243996,0.00006155909,0.0030899053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983801,0.000048138798,0.00030617273,0.00053759833,0.0002867625,0.00044119492],"domain_scores_gemma":[0.9990536,0.000087767396,0.000095934476,0.0002509513,0.00025864938,0.0002531217],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00019645474,0.00023538305,0.00054599496,0.0001168592,0.00007178673,0.000030406449,0.0000663125,0.00010833067,0.002228404],"category_scores_gemma":[0.00004141077,0.00021679609,0.00013708604,0.0003278083,0.00010008368,0.00012989086,0.000028438035,0.00022826077,0.000006728349],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064861816,0.00048569197,0.16364588,0.0012420687,0.0008968263,0.00038540649,0.0021721025,0.000082988205,0.026054919,0.00049526436,0.025718557,0.7723341],"study_design_scores_gemma":[0.04159743,0.00050663576,0.8091786,0.0016310188,0.0012738465,0.0026699293,0.004313122,0.0005022534,0.071064666,0.0013025845,0.06451789,0.0014420555],"about_ca_topic_score_codex":0.007264384,"about_ca_topic_score_gemma":0.007932767,"teacher_disagreement_score":0.7708921,"about_ca_system_score_codex":0.0006459947,"about_ca_system_score_gemma":0.0013844514,"threshold_uncertainty_score":0.9993463},"labels":[],"label_agreement":null},{"id":"W3153071119","doi":"10.1038/s41523-021-00251-7","title":"Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institute for Health and Care Research; Astex Pharmaceuticals; Memorial Sloan-Kettering Cancer Center; AstraZeneca; National Cancer Institute; National Institutes of Health; Cancer Research UK; Breast Cancer Research Foundation","keywords":"Fulvestrant; PTEN; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Anastrozole; Cancer; Aromatase inhibitor; Cancer research; Estrogen receptor; PI3K/AKT/mTOR pathway; Biology; Aromatase; Signal transduction","score_opus":0.007119816247072573,"score_gpt":0.25377119702037226,"score_spread":0.24665138077329968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153071119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932514,0.0024229027,0.0002737988,0.0017337821,0.00032251555,0.0004787309,0.0012710437,0.00002150665,0.00022432428],"genre_scores_gemma":[0.9977775,0.00029660494,0.0001706233,0.0006265066,0.00027864805,0.0004699872,0.00017982452,0.00007195625,0.00012830546],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99752814,0.00021071985,0.00041363534,0.00087088207,0.00037517972,0.0006014284],"domain_scores_gemma":[0.9987625,0.000030900297,0.00017701379,0.00034962795,0.0005222887,0.00015770632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00019161873,0.0003942527,0.0004237906,0.00013710192,0.00007594695,0.00005136174,0.00019098893,0.00017923574,0.00023240925],"category_scores_gemma":[0.000022760407,0.00037209305,0.00009332137,0.0006444713,0.00015001382,0.00003284375,0.00007822329,0.00035183597,0.0000052400433],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002103702,0.00082450715,0.06496813,0.00014766966,0.00035512637,0.00037564183,0.00054636726,0.0042095273,0.9120866,0.000063963125,0.00039735477,0.013921376],"study_design_scores_gemma":[0.0059856796,0.00030266427,0.26819733,0.00089354976,0.00013162593,0.0004726997,0.00039339418,0.0005253923,0.72179663,0.000105273815,0.0003778109,0.00081795873],"about_ca_topic_score_codex":0.0046273666,"about_ca_topic_score_gemma":0.016908621,"teacher_disagreement_score":0.2032292,"about_ca_system_score_codex":0.000697564,"about_ca_system_score_gemma":0.0014566915,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W3160306401","doi":"10.1038/s41523-021-00255-3","title":"Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Université Laval; Lunenfeld-Tanenbaum Research Institute; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Instituto de Salud Carlos III; Medical Research Council; Freistaat Sachsen; Unicancer; Canadian Institutes of Health Research; Direction Générale de l’offre de Soins; Universität Leipzig; National Health and Medical Research Council; Institut National Du Cancer; Agence Nationale de la Recherche; Cancer Australia; European Regional Development Fund; National Breast Cancer Foundation; Fundación Cellex; European Commission; University of Cambridge; Cancer Research UK; Centres de Recerca de Catalunya; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; Government of Canada; Fondation du cancer du sein du Québec; Generalitat de Catalunya; National Institute for Health and Care Research; Genome Canada; Cancer Council Victoria; Deutsche Krebshilfe; Victorian Cancer Agency","keywords":"Breast cancer; Missense mutation; Germline mutation; Germline; Allele; Male breast cancer; Haploinsufficiency; Penetrance; Genetics; Biology; PALB2; Cancer; Oncology; Cancer research; Medicine; Mutation; Gene; Phenotype","score_opus":0.025901240004550078,"score_gpt":0.3266547738514796,"score_spread":0.30075353384692954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160306401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99665415,0.00015441435,0.000015441128,0.0005263646,0.0007848013,0.0008377702,0.00084312866,0.000008592125,0.00017533926],"genre_scores_gemma":[0.9992765,0.000043032458,0.000091375245,0.000079871854,0.00019039448,0.00019483869,0.00003606057,0.00002551214,0.00006239018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970443,0.00032196025,0.0004942485,0.00034009173,0.0016152892,0.00018407656],"domain_scores_gemma":[0.9963283,0.00003698776,0.0005038867,0.000370865,0.0027035414,0.000056436453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057870895,0.00016561698,0.00037659163,0.00010381427,0.000026263562,0.000008740745,0.00016608968,0.00010518001,0.0007526537],"category_scores_gemma":[0.000070968956,0.00012414671,0.00007973609,0.00040633726,0.000056263314,0.00014379599,0.00006806745,0.00018010383,4.3873067e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010072449,0.003204761,0.96876353,0.00008279274,0.00050136424,0.0000038901585,0.0016094211,0.0031137287,0.013283818,0.0000016052061,0.000029672963,0.008398185],"study_design_scores_gemma":[0.0104795685,0.00024998264,0.9773876,0.0005547448,0.00051945157,0.00007082531,0.0003606914,0.0035964837,0.006666663,0.000004786722,0.0000054773986,0.00010374727],"about_ca_topic_score_codex":0.0026614824,"about_ca_topic_score_gemma":0.016323429,"teacher_disagreement_score":0.013661946,"about_ca_system_score_codex":0.0011580646,"about_ca_system_score_gemma":0.0009471825,"threshold_uncertainty_score":0.91088563},"labels":[],"label_agreement":null},{"id":"W3161898366","doi":"10.1038/s41523-021-00264-2","title":"NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Jewish General Hospital; Montreal General Hospital","funders":"National Cancer Institute; American College of Radiology Imaging Network; Genentech; F. Hoffmann-La Roche; Breast Cancer Research Foundation","keywords":"Medicine; Trastuzumab; Amenorrhea; Gynecology; Breast cancer; Oophorectomy; Internal medicine; Oncology; Triptorelin; Obstetrics; Hysterectomy; Cancer; Hormone; Luteinizing hormone; Pregnancy; Surgery; Gonadotropin-releasing hormone","score_opus":0.006946025991060778,"score_gpt":0.28215748754823666,"score_spread":0.2752114615571759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161898366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914497,0.0072792624,0.000018138922,0.0000933958,0.00010409184,0.00020458653,0.000044179797,0.000010216985,0.00079642015],"genre_scores_gemma":[0.99863905,0.000574657,0.000119655786,0.00010534102,0.0001315257,0.000030866682,0.000020034002,0.00003245181,0.00034643337],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9990587,0.00008347756,0.00015535821,0.0003520909,0.00013226553,0.0002180654],"domain_scores_gemma":[0.99940807,0.0000062126537,0.00010498079,0.00024233726,0.00012609285,0.00011233433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000088970424,0.00019392019,0.00030316442,0.00002686652,0.00003529014,0.000005811894,0.00007766269,0.00016779544,0.00013366851],"category_scores_gemma":[0.000004198464,0.00014158596,0.00008649826,0.000060875554,0.00015768825,0.0000046678374,0.00003940313,0.00014530646,0.0000012326336],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027324469,0.00087910285,0.29341462,0.000038144815,0.0016278202,0.00005516193,0.00083401706,0.000080244165,0.6296368,0.000005114365,0.002611917,0.0680846],"study_design_scores_gemma":[0.012028867,0.005915162,0.8788448,0.00010337798,0.00036983882,0.0014909952,0.00071529945,0.00007310246,0.09263751,0.000006043177,0.00717836,0.00063665916],"about_ca_topic_score_codex":0.00028127845,"about_ca_topic_score_gemma":0.000104589155,"teacher_disagreement_score":0.5854302,"about_ca_system_score_codex":0.0002124114,"about_ca_system_score_gemma":0.00086236035,"threshold_uncertainty_score":0.57737076},"labels":[],"label_agreement":null},{"id":"W3164338067","doi":"10.1038/s41523-021-00266-0","title":"Anti-tumor effects of an ID antagonist with no observed acquired resistance","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"TGF-β signaling in diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Social Fund; Fonds de Recherche du Québec - Santé; National Cancer Institute; National Institutes of Health; Botwinick-Wolfensohn Foundation; Fonds de recherche du Québec – Nature et technologies; American Concrete Institute Foundation; Generalitat Valenciana; Memorial Sloan-Kettering Cancer Center; Breast Cancer Research Foundation","keywords":"Paclitaxel; Cancer research; Biology; Reactive oxygen species; Transcription factor; Cell growth; Cancer; Cell biology; Biochemistry; Gene; Genetics","score_opus":0.006295913903447121,"score_gpt":0.23358899867716773,"score_spread":0.22729308477372062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164338067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958188,0.0031820813,0.00006322068,0.00007963994,0.00018652131,0.00012565788,0.00022941397,0.000021715003,0.00029293253],"genre_scores_gemma":[0.99759585,0.00004732161,0.00073429156,0.0003670459,0.00034394028,0.000050863113,0.00018756023,0.000039935425,0.0006332232],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99889916,0.00007291756,0.00017099465,0.00042876997,0.00018488128,0.00024328264],"domain_scores_gemma":[0.9989475,0.000014562608,0.00011871471,0.00052281923,0.00029185732,0.000104542974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000046693687,0.0001756422,0.00022335998,0.000015238355,0.000070650254,0.000026197196,0.00019515009,0.000071210336,0.000089419664],"category_scores_gemma":[0.000039663806,0.00015942618,0.00006111046,0.000104172315,0.00013113196,0.0000079747915,0.00006210872,0.00003987471,0.000004936895],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057189364,0.00018922861,0.014440455,0.00032910384,0.000103961174,0.000085427484,0.000015424954,0.00004628802,0.982781,0.00000814212,0.000989504,0.00043958292],"study_design_scores_gemma":[0.0009209188,0.000085384214,0.15885282,0.0001907035,0.00005322099,0.000029169332,0.000013708792,0.000009403288,0.8332027,0.000003873127,0.0064286594,0.00020944592],"about_ca_topic_score_codex":0.000055810917,"about_ca_topic_score_gemma":0.00029358245,"teacher_disagreement_score":0.1495783,"about_ca_system_score_codex":0.000022823993,"about_ca_system_score_gemma":0.00043494583,"threshold_uncertainty_score":0.6501211},"labels":[],"label_agreement":null},{"id":"W3167217140","doi":"10.1038/s41523-021-00275-z","title":"Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Université Laval; McMaster University; Juravinski Cancer Centre; University of British Columbia; Saint John Regional Hospital; Roche (Canada); BC Cancer Agency; Niagara Health System; Grand River Hospital; Queen's University; Princess Margaret Cancer Centre; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"National Cancer Institute; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Metformin; Placebo; Medicine; Breast cancer; Oncology; Internal medicine; Randomized controlled trial; Cancer; Insulin; Pathology; Alternative medicine","score_opus":0.010174329374079399,"score_gpt":0.2891731375598405,"score_spread":0.27899880818576106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167217140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90009636,0.095415324,0.000007713246,0.0001520287,0.0018818807,0.0009142474,0.0006667366,0.000009267205,0.00085642544],"genre_scores_gemma":[0.962799,0.034012116,0.000011307967,0.00040062313,0.0013795778,0.00104496,0.00010436974,0.000045855555,0.00020219633],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99721295,0.00096998236,0.0004415586,0.0005101084,0.00041940814,0.00044602228],"domain_scores_gemma":[0.9986978,0.00029762246,0.00022254394,0.0005484935,0.00013862325,0.000094928335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010743416,0.0003653971,0.00094475155,0.0000742109,0.00006462789,0.000033873337,0.00034459692,0.00022141912,0.00084350596],"category_scores_gemma":[0.00016020532,0.00022937571,0.00048118277,0.0002848389,0.00016369447,0.00001123036,0.00007076755,0.00022760658,0.0000051448724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.77253836,0.00019945872,0.0010095426,0.000099314144,0.0007900801,0.000007005394,0.00023818272,0.00018471132,0.010969813,0.00019701447,0.0014603358,0.21230619],"study_design_scores_gemma":[0.66544867,0.00030797772,0.003029778,0.000100836936,0.0007843172,0.000021772512,0.00014552627,0.000029552257,0.26829243,0.000021491069,0.06131107,0.0005065805],"about_ca_topic_score_codex":0.0010448752,"about_ca_topic_score_gemma":0.0006678285,"teacher_disagreement_score":0.2573226,"about_ca_system_score_codex":0.000053011765,"about_ca_system_score_gemma":0.000396175,"threshold_uncertainty_score":0.935367},"labels":[],"label_agreement":null},{"id":"W3169325545","doi":"10.1038/s41523-021-00281-1","title":"Circulating tumor cell number and endocrine therapy index in ER positive metastatic breast cancer patients","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sinai Health System; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Menarini Silicon Biosystems; Fashion Footwear Association of New York","keywords":"Medicine; Metastatic breast cancer; Circulating tumor cell; Internal medicine; Oncology; Progression-free survival; Clinical endpoint; Estrogen receptor; Cancer; Breast cancer; Metastasis; Chemotherapy; Clinical trial","score_opus":0.011549705273601092,"score_gpt":0.28419366661870843,"score_spread":0.2726439613451073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169325545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909198,0.0031113364,0.000019168028,0.0016482808,0.00034480044,0.00047409793,0.0011054015,0.000028881654,0.0023482237],"genre_scores_gemma":[0.9947926,0.0014118376,0.00016438603,0.0024763008,0.00027376538,0.00018778844,0.000058985253,0.00006735605,0.000567026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797153,0.000088716195,0.00039507856,0.0005894281,0.000429963,0.00052528625],"domain_scores_gemma":[0.9988953,0.000050598144,0.00015622492,0.0002549581,0.0003922429,0.000250705],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00009836131,0.0003205178,0.0005844243,0.000095319345,0.00007361698,0.00004492467,0.00006517089,0.000045064327,0.0049111755],"category_scores_gemma":[0.000009021584,0.00028127202,0.00012399814,0.00045905623,0.00008046017,0.0001693164,0.00007300666,0.00031557796,0.000013949968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004631578,0.00065218046,0.88331044,0.00021585541,0.0002164154,0.00038650946,0.0005574324,0.000053518237,0.0057735946,0.000010714537,0.00043546603,0.107924744],"study_design_scores_gemma":[0.0074729547,0.00003538073,0.9830522,0.00042462652,0.00017798338,0.000984261,0.00023123415,0.00011450277,0.0056677153,0.000028999511,0.0014824717,0.00032769353],"about_ca_topic_score_codex":0.008821706,"about_ca_topic_score_gemma":0.0010605492,"teacher_disagreement_score":0.10759705,"about_ca_system_score_codex":0.000411938,"about_ca_system_score_gemma":0.0005087336,"threshold_uncertainty_score":0.99996394},"labels":[],"label_agreement":null},{"id":"W3180645260","doi":"10.1038/s41523-021-00297-7","title":"Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Ontario Institute for Cancer Research","funders":"University College London; Government of Ontario; National Cancer Institute; Ontario Institute for Cancer Research; Canadian Institutes of Health Research; National Institute for Health and Care Research; Genome Canada","keywords":"Medicine; Risk stratification; Oncology; Internal medicine; Breast cancer; Cancer","score_opus":0.021370798486590563,"score_gpt":0.3242992406460176,"score_spread":0.30292844215942705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180645260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940919,0.0031826163,0.0002347677,0.000255765,0.00022510489,0.000306772,0.00083208724,0.00002046721,0.0008505053],"genre_scores_gemma":[0.99857825,0.00011033738,0.00041480933,0.00015901659,0.00012262809,0.00018882715,0.00024138682,0.000029430497,0.00015530211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776685,0.00027514962,0.0003987076,0.00083117903,0.0003412293,0.00038689573],"domain_scores_gemma":[0.9982746,0.000083082836,0.00022377916,0.0007438362,0.00056120753,0.000113455346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014369328,0.00035163044,0.00087373884,0.00021736752,0.000090158326,0.000019179402,0.00024790605,0.00013622279,0.00017839084],"category_scores_gemma":[0.00007953521,0.00032314585,0.00030723537,0.0012553134,0.00020375193,0.0000071865925,0.00028827152,0.00012402087,0.0000071975574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002385406,0.0015618091,0.93539184,0.000016389207,0.0068979664,0.000074249656,0.000825118,0.0012090163,0.04991996,0.000016030312,0.000347421,0.0035016786],"study_design_scores_gemma":[0.0016404988,0.00016553425,0.9766591,0.000013204033,0.0021878753,0.00003469027,0.0012129471,0.00007780303,0.017395675,0.000016185015,0.0002728,0.00032364723],"about_ca_topic_score_codex":0.0010184633,"about_ca_topic_score_gemma":0.004205147,"teacher_disagreement_score":0.04126732,"about_ca_system_score_codex":0.00009836814,"about_ca_system_score_gemma":0.00021001158,"threshold_uncertainty_score":0.99992204},"labels":[],"label_agreement":null},{"id":"W3181590127","doi":"10.1038/s41523-021-00299-5","title":"High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Science and Technology, Taiwan; National Taiwan University Hospital; National Research Foundation Singapore; Cancer Research UK; BC Cancer Agency; Ministry of Education; National Taiwan University; Ministry of Education - Singapore; National Research Foundation; Ministry of Health and Welfare","keywords":"Breast cancer; Copy-number variation; Medicine; Oncology; Estrogen receptor; Cancer; Incidence (geometry); Immune system; Gene; East Asia; Internal medicine; Cancer research; Biology; Immunology; Genetics; China","score_opus":0.010257244113006107,"score_gpt":0.2576346292176395,"score_spread":0.24737738510463342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3181590127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349636,0.0012776199,0.000024142077,0.0024471302,0.00045000837,0.00040692967,0.0005588111,0.00002996326,0.0013090506],"genre_scores_gemma":[0.9966958,0.0006264047,0.00010424807,0.00027507308,0.00036533579,0.0007835376,0.000029169172,0.000040773702,0.0010796272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754745,0.00010009636,0.0005963747,0.0005898231,0.0004967926,0.0006694891],"domain_scores_gemma":[0.99879384,0.000023319366,0.00017298503,0.00042130883,0.00029168863,0.00029686323],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002704717,0.00026907495,0.0005928242,0.00021638775,0.00005722046,0.000030212315,0.0001662712,0.00013781682,0.003466191],"category_scores_gemma":[0.000025145586,0.0002671615,0.000110380926,0.0008555565,0.00019296474,0.00026605127,0.000060770308,0.00036434125,0.000007709254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048957806,0.0003260993,0.980141,0.0007172297,0.00008716089,0.000092415066,0.002325857,0.00067122275,0.0020979296,0.000079899786,0.0006174755,0.012354132],"study_design_scores_gemma":[0.002235316,0.00007269003,0.9918953,0.0013897297,0.00008291335,0.00030526682,0.0013500118,0.00041166713,0.0018193114,0.00002862977,0.0001547231,0.00025443264],"about_ca_topic_score_codex":0.020831652,"about_ca_topic_score_gemma":0.013161685,"teacher_disagreement_score":0.012099699,"about_ca_system_score_codex":0.002131433,"about_ca_system_score_gemma":0.0015694232,"threshold_uncertainty_score":0.99997807},"labels":[],"label_agreement":null},{"id":"W3184508197","doi":"10.1038/s41523-021-00307-8","title":"Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Reproductive Biology and Fertility","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Trastuzumab; Pertuzumab; Docetaxel; Internal medicine; Oncology; Tamoxifen; Population; Prospective cohort study; Gynecology; Cohort; Amenorrhea; Cancer; Pregnancy","score_opus":0.009360194591843056,"score_gpt":0.27401105206301024,"score_spread":0.2646508574711672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3184508197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955381,0.0007708071,0.0000033932884,0.00066651177,0.00013871335,0.0014203256,0.00020269195,0.00003743059,0.0012220237],"genre_scores_gemma":[0.9970618,0.00014026735,0.000010997948,0.00004187453,0.00010304801,0.0014117609,0.000013220703,0.000026895963,0.0011901205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981809,0.0001153673,0.00032428282,0.00079068635,0.00022676303,0.00036197534],"domain_scores_gemma":[0.9987658,0.000015632571,0.00012576573,0.00051247765,0.00046531946,0.000114963805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013662755,0.00024751088,0.000682549,0.000075104545,0.00005456825,0.000006224665,0.00006146054,0.0001155193,0.00083826046],"category_scores_gemma":[0.000010533077,0.00017250115,0.000043546454,0.0004543611,0.00016895424,0.00009739113,0.00003256582,0.00022318408,0.0000033368085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013807092,0.0028590658,0.9628889,0.0000362938,0.0011672566,0.000121288685,0.005974248,0.00007156741,0.002440485,0.0000043748464,0.000008268919,0.010621167],"study_design_scores_gemma":[0.00637016,0.00067320827,0.9890339,0.00009721711,0.00023567436,0.0005235312,0.0021567866,0.00007322275,0.0006122269,0.000052154897,0.000008768605,0.00016317022],"about_ca_topic_score_codex":0.008458297,"about_ca_topic_score_gemma":0.0042204983,"teacher_disagreement_score":0.026144987,"about_ca_system_score_codex":0.0015014989,"about_ca_system_score_gemma":0.00067942153,"threshold_uncertainty_score":0.99814445},"labels":[],"label_agreement":null},{"id":"W3186156042","doi":"10.1038/s41523-021-00304-x","title":"Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Statistics Canada; University of Toronto","funders":"Breast Cancer Research Foundation","keywords":"CD68; Hazard ratio; Breast cancer; Medicine; Internal medicine; Adipose tissue; Immunohistochemistry; Confidence interval; Proportional hazards model; Cancer; Oncology; Endocrinology; Pathology","score_opus":0.00974374986901148,"score_gpt":0.27132533089478406,"score_spread":0.26158158102577256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186156042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98927647,0.002759454,0.0000062928875,0.00092602905,0.00029172242,0.00048676098,0.0061216746,0.000045891382,0.0000857108],"genre_scores_gemma":[0.9979692,0.00096265,0.00008683501,0.00025230093,0.00021625502,0.00013825117,0.00016773323,0.00005863855,0.00014814446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978631,0.00007282166,0.00044738385,0.0005643963,0.00060681335,0.00044547705],"domain_scores_gemma":[0.9983376,0.000045753408,0.00030094487,0.00030096303,0.0007304166,0.00028428037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000070693444,0.0003682776,0.00077896245,0.0001902484,0.00011414756,0.000048149835,0.00011691148,0.00018518546,0.0015089236],"category_scores_gemma":[0.000015148595,0.0002692909,0.00009689561,0.0006244519,0.00015656516,0.0002725303,0.00010541104,0.00031790914,0.0000012327042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029195388,0.0004826871,0.9801075,0.00012974208,0.00025902412,0.00001083402,0.0010684306,0.000025868549,0.0026136988,0.000018380531,0.0007401387,0.014251742],"study_design_scores_gemma":[0.0025612698,0.000047011035,0.9900319,0.0004907109,0.000391946,0.000101489546,0.00022538092,0.0000075957805,0.0049614324,0.000018558016,0.00086314237,0.00029957012],"about_ca_topic_score_codex":0.023316188,"about_ca_topic_score_gemma":0.011783241,"teacher_disagreement_score":0.013952171,"about_ca_system_score_codex":0.00033490613,"about_ca_system_score_gemma":0.0006514452,"threshold_uncertainty_score":0.9999759},"labels":[],"label_agreement":null},{"id":"W3186178212","doi":"10.1038/s41523-021-00305-w","title":"IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cytokine Signaling Pathways and Interactions","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; Weston Park Cancer Charity; Trent University; British Heart Foundation; Nottingham Trent University","keywords":"Medicine; Breast cancer; Bone metastasis; Metastasis; Immune system; Cancer research; Cytokine; Anakinra; Cancer; Oncology; Internal medicine; Immunology; Disease","score_opus":0.022761611898643598,"score_gpt":0.31744167291300474,"score_spread":0.2946800610143611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186178212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423846,0.0022105733,0.000049174196,0.021976348,0.00038281485,0.00028486957,0.00061063905,0.000037413185,0.00020972667],"genre_scores_gemma":[0.99677294,0.00027483795,0.00032216188,0.0019081535,0.00017215885,0.00013902549,0.000034247834,0.00003827041,0.0003381805],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984709,0.00012218831,0.00042231157,0.00042567364,0.00024678383,0.00031211285],"domain_scores_gemma":[0.99922496,0.000113107766,0.00011261179,0.00019983084,0.00021623219,0.00013323952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026450754,0.00021385921,0.00046794163,0.00033830965,0.00009177801,0.0000896009,0.00005120624,0.000067048815,0.00036420004],"category_scores_gemma":[0.00005309976,0.0001963133,0.00007369651,0.0004301535,0.00006506052,0.0003052038,0.000067397465,0.00031266667,0.000002776548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009548841,0.00037262152,0.4419053,0.00014471448,0.000057351186,0.00015065796,0.0012957033,0.00004010685,0.47676125,0.00005690324,0.00019892161,0.078061596],"study_design_scores_gemma":[0.002523404,0.00004908415,0.9785952,0.0011274236,0.00007935439,0.00042349633,0.00078072166,0.00022684243,0.015215003,0.000032477248,0.0007240041,0.00022297683],"about_ca_topic_score_codex":0.003138014,"about_ca_topic_score_gemma":0.0011305986,"teacher_disagreement_score":0.53668994,"about_ca_system_score_codex":0.00062088383,"about_ca_system_score_gemma":0.0004925045,"threshold_uncertainty_score":0.8005424},"labels":[],"label_agreement":null},{"id":"W3186622353","doi":"10.1038/s41523-021-00301-0","title":"Evaluation of multiple transcriptomic gene risk signatures in male breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Male Breast Health Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Government of Ontario; Ontario Institute for Cancer Research; Breast Cancer Research Foundation","keywords":"Concordance; Oncology; Breast cancer; Medicine; Subtyping; Internal medicine; Cancer; Gene signature; Univariate analysis; Univariate; Gynecology; Gene; Multivariate analysis; Gene expression; Biology; Genetics; Multivariate statistics","score_opus":0.02990180125828365,"score_gpt":0.33546001534381364,"score_spread":0.30555821408552997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186622353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652914,0.024842927,0.000024052857,0.005313035,0.0005813341,0.0007703838,0.002058539,0.000037788803,0.0010805817],"genre_scores_gemma":[0.9949763,0.0028380412,0.0002232187,0.0005276727,0.0005218448,0.0004427008,0.000029199111,0.00004374233,0.00039732628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709827,0.00029318995,0.00053853943,0.0005185172,0.0010854668,0.00046600247],"domain_scores_gemma":[0.9977075,0.00007326981,0.00021959587,0.0003812471,0.001449814,0.00016859069],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00086491276,0.0002595606,0.00061036146,0.00016444415,0.00007915334,0.000008361473,0.000100460566,0.00017554851,0.006880613],"category_scores_gemma":[0.000098780474,0.00023924922,0.0001432244,0.00048578743,0.00010759216,0.00010194536,0.00003982403,0.00040004894,0.00000984927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009784063,0.00040889182,0.8298997,0.00055569375,0.00028155273,0.000034744742,0.0008258426,0.003034743,0.024201186,0.00000917641,0.0016780276,0.138092],"study_design_scores_gemma":[0.005748699,0.000022899885,0.98017615,0.0005823932,0.0007106454,0.00030931085,0.0002228637,0.0072001326,0.0043721995,0.000030232171,0.00042143682,0.00020305642],"about_ca_topic_score_codex":0.013735387,"about_ca_topic_score_gemma":0.018105853,"teacher_disagreement_score":0.1502764,"about_ca_system_score_codex":0.0008343316,"about_ca_system_score_gemma":0.0019538014,"threshold_uncertainty_score":0.9998112},"labels":[],"label_agreement":null},{"id":"W3193416718","doi":"10.1038/s41523-021-00315-8","title":"Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Centre Hospitalier de l’Université de Montréal; McGill University; Université de Montréal; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Cancer Society Research Institute; Fondation du cancer du sein du Québec; Cancer Research Society","keywords":"Homologous recombination; Proband; Breast cancer; Gene; Homologous chromosome; Genetics; Biology; Recombination; DNA repair; Cancer; Mutation","score_opus":0.0180938311625258,"score_gpt":0.28182242959528936,"score_spread":0.2637285984327636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3193416718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880921,0.0037685942,0.00059038604,0.0007929502,0.0016692028,0.00055543054,0.0043537566,0.00013190541,0.00004562996],"genre_scores_gemma":[0.9936518,0.0020360027,0.00059994945,0.00059784856,0.000599549,0.0009013025,0.00086469395,0.00008673586,0.00066211063],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978757,0.00011843903,0.00036766534,0.00083805615,0.00023859569,0.00056154025],"domain_scores_gemma":[0.99824846,0.00003474606,0.00021843307,0.0005106731,0.0008340186,0.00015370044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024728788,0.0003336253,0.00031817087,0.00005522009,0.00016943007,0.000060447033,0.00018521653,0.00030584255,0.00019598546],"category_scores_gemma":[0.00008110829,0.00034469747,0.0003082624,0.00016689296,0.000064688036,0.00002014952,0.00015992887,0.00016435409,0.000008385918],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066534086,0.0010078242,0.019777084,0.0002002983,0.0010461822,0.0002824934,0.00027586872,0.000361521,0.79176533,0.00006677261,0.008801321,0.17574997],"study_design_scores_gemma":[0.011750894,0.00056042033,0.17890406,0.00042992563,0.0010041071,0.008698968,0.00070966635,0.0068987543,0.7239963,0.0004441489,0.06386679,0.002736006],"about_ca_topic_score_codex":0.0014353358,"about_ca_topic_score_gemma":0.0019763364,"teacher_disagreement_score":0.17301397,"about_ca_system_score_codex":0.00032362223,"about_ca_system_score_gemma":0.00048833987,"threshold_uncertainty_score":0.9999005},"labels":[],"label_agreement":null},{"id":"W3197447043","doi":"10.1038/s41523-021-00325-6","title":"Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Region Midtjylland; Novo Nordisk Fonden; Steno Diabetes Center Aarhus; Aarhus Universitet","keywords":"Triple-negative breast cancer; Meta-analysis; Overweight; Medicine; Breast cancer; Oncology; Cancer; Triple negative; Internal medicine; Obesity","score_opus":0.051448354866789045,"score_gpt":0.36366941953809534,"score_spread":0.3122210646713063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197447043","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016697755,0.98583144,0.0000010741272,0.00069827505,0.00009370346,0.0056698164,0.007598468,0.000029605422,0.000060906612],"genre_scores_gemma":[0.0002365685,0.9904559,0.000018814604,0.0008201003,0.00010166691,0.007409688,0.00019904347,0.00009216044,0.0006660469],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9956448,0.0004590695,0.0016150611,0.0011741814,0.00062790187,0.0004789681],"domain_scores_gemma":[0.99731606,0.00018917694,0.0011017951,0.0005774084,0.00046840118,0.00034713026],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000396758,0.0009367559,0.01392954,0.00051478896,0.000071487026,0.00008384954,0.00016149777,0.000328434,0.003342869],"category_scores_gemma":[0.000075156124,0.00058229483,0.0021987695,0.0021061306,0.00012981704,0.00017100666,0.00014201774,0.00060772017,0.00000500063],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001986536,0.00019910293,0.0039874776,0.81521994,0.1391716,0.000028442804,0.000107729,1.3198799e-7,8.881469e-9,0.0000059233967,0.00059119996,0.040668584],"study_design_scores_gemma":[0.00063043396,0.000030588344,0.0046192463,0.15954518,0.8228275,0.00021535243,0.000019560086,0.000002369556,6.1594406e-8,0.0000012850118,0.011573207,0.0005351663],"about_ca_topic_score_codex":0.006505605,"about_ca_topic_score_gemma":0.0026804437,"teacher_disagreement_score":0.6836559,"about_ca_system_score_codex":0.0009051402,"about_ca_system_score_gemma":0.0007180417,"threshold_uncertainty_score":0.9996629},"labels":[],"label_agreement":null},{"id":"W3198037870","doi":"10.1038/s41523-021-00320-x","title":"Proteomics-derived basal biomarker DNA-PKcs is associated with intrinsic subtype and long-term clinical outcomes in breast cancer","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Government of Canada","keywords":"Breast cancer; Tissue microarray; DNA-PKcs; Biomarker; Cancer research; Biology; Cancer; Immune system; DNA microarray; Immune checkpoint; Immunohistochemistry; Medicine; DNA damage; DNA; Gene; Gene expression; Immunotherapy; Immunology; Genetics","score_opus":0.015655547269751595,"score_gpt":0.29123154499439274,"score_spread":0.27557599772464114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198037870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929693,0.0012912949,0.000041374842,0.0035335382,0.0003819079,0.00029716236,0.0013926291,0.000013138822,0.000079690784],"genre_scores_gemma":[0.99228066,0.003770287,0.00010814158,0.0029021276,0.00032441303,0.00013508085,0.00015661627,0.000059027465,0.00026363114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982196,0.00008629238,0.00039830347,0.000699412,0.00017065802,0.0004257422],"domain_scores_gemma":[0.9989083,0.00005048173,0.0001902533,0.000374259,0.00028883465,0.00018791086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00017279178,0.0002984658,0.0004444109,0.00004948025,0.00007002294,0.00007342374,0.00015405992,0.0002988772,0.0002590544],"category_scores_gemma":[0.00006494075,0.00026720943,0.000114651826,0.00018479988,0.0001967596,0.000010754362,0.00020282346,0.00020621582,0.0000037372786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707978,0.00021395469,0.96340233,0.000025755582,0.0003600773,0.00006386214,0.00003353119,0.000008144405,0.023016818,0.0000062206445,0.0008929808,0.011405538],"study_design_scores_gemma":[0.0027848762,0.000063036634,0.98830354,0.00012538259,0.0000881757,0.000077670855,0.000016449532,0.000024716985,0.00783002,0.000017004628,0.0002822922,0.00038683863],"about_ca_topic_score_codex":0.00077460025,"about_ca_topic_score_gemma":0.009470846,"teacher_disagreement_score":0.024901217,"about_ca_system_score_codex":0.00014296036,"about_ca_system_score_gemma":0.0009183306,"threshold_uncertainty_score":0.999978},"labels":[],"label_agreement":null},{"id":"W3198768601","doi":"10.1038/s41523-021-00322-9","title":"Clinical consequences of BRCA2 hypomorphism","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"European Regional Development Fund; Instituto de Salud Carlos III; Institució Catalana de Recerca i Estudis Avançats; Centres de Recerca de Catalunya; Fundación Cellex; Agència de Gestió d'Ajuts Universitaris i de Recerca; Ministerio de Economía y Competitividad; Generalitat de Catalunya; European Commission; Fanconi Anemia Research Fund","keywords":"Fanconi anemia; RAD51; Missense mutation; Allele; Breast cancer; Cancer research; BRCA2 Protein; Biology; Ovarian cancer; DNA repair; Phenotype; Chemotherapy; DNA damage; Genetics; Cancer; Mutation; Germline mutation; DNA; Gene","score_opus":0.015509870257282326,"score_gpt":0.35314096221716623,"score_spread":0.3376310919598839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3198768601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862364,0.008528494,0.001792949,0.00082030625,0.0006026457,0.000053698357,0.00013651756,0.00000946901,0.0018195136],"genre_scores_gemma":[0.9972,0.0010790775,0.0006095671,0.00024352291,0.00033820843,0.000007648962,0.000020464839,0.000009854916,0.0004916651],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99939775,0.000025159956,0.00018305708,0.00019805574,0.000075120995,0.00012082615],"domain_scores_gemma":[0.9995773,0.0000090811645,0.000039861385,0.00020184241,0.00011450451,0.000057414058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008156343,0.00007269553,0.00012436586,0.000009533544,0.000015943271,0.000005151575,0.00007939806,0.00008663449,0.0002567536],"category_scores_gemma":[0.000026983555,0.00007061471,0.00008455742,0.000049288534,0.00011188754,0.0000010288333,0.000048537713,0.000054572367,0.0000039597066],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037452493,0.000049935723,0.059298083,0.000028915592,0.00009288864,0.000011172919,0.000014760002,0.0002464471,0.8991287,0.00006438168,0.003040552,0.037986703],"study_design_scores_gemma":[0.00058556587,0.00005530734,0.1721253,0.000042423962,0.00003504995,0.00019321924,0.000044549277,0.00004437811,0.7817321,0.000054063956,0.04490075,0.00018731391],"about_ca_topic_score_codex":0.000050502204,"about_ca_topic_score_gemma":0.000044377168,"teacher_disagreement_score":0.11739662,"about_ca_system_score_codex":0.0000051716984,"about_ca_system_score_gemma":0.0001773012,"threshold_uncertainty_score":0.28795844},"labels":[],"label_agreement":null},{"id":"W3207569082","doi":"10.1038/s41523-021-00345-2","title":"Breast Cancer Consensus Subtypes: A system for subtyping breast cancer tumors based on gene expression","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"BC Cancer Agency; Cancer Research UK","keywords":"Subtyping; Breast cancer; Stromal cell; Cancer research; Oncology; Medicine; Lymphocytic infiltration; Androgen receptor; Estrogen receptor; Internal medicine; Pathology; Biology; Cancer; Prostate cancer","score_opus":0.01155565826883234,"score_gpt":0.26406708579937455,"score_spread":0.25251142753054223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207569082","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89362484,0.01826994,0.001098555,0.019818045,0.004493015,0.0022173342,0.059066594,0.0003941045,0.0010175823],"genre_scores_gemma":[0.99210536,0.00050227885,0.00043780153,0.001282113,0.0023355747,0.0023231742,0.000379703,0.00017885974,0.0004551412],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9963729,0.00015614189,0.000540967,0.0014726792,0.00047324772,0.0009840708],"domain_scores_gemma":[0.99742097,0.00007347947,0.00035928385,0.00087495724,0.0009521014,0.00031922967],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016962714,0.0007417178,0.00072750903,0.00010998462,0.00047354322,0.00008177418,0.0003260237,0.00033202764,0.00042056557],"category_scores_gemma":[0.000017360866,0.0006726157,0.0003876276,0.00032880617,0.00020397332,0.000014801188,0.00017816633,0.00021847228,0.000014109561],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01529561,0.0011880946,0.29798743,0.0020386074,0.0021861813,0.00024633622,0.00033593093,0.011952604,0.5889167,0.00012805875,0.026068522,0.0536559],"study_design_scores_gemma":[0.011873743,0.00014851628,0.4884902,0.0044809314,0.00086426083,0.0026798304,0.000872267,0.001631939,0.48059055,0.000016444012,0.0060240007,0.0023273244],"about_ca_topic_score_codex":0.0028883368,"about_ca_topic_score_gemma":0.0014717163,"teacher_disagreement_score":0.19050278,"about_ca_system_score_codex":0.0008603662,"about_ca_system_score_gemma":0.0016483404,"threshold_uncertainty_score":0.9995725},"labels":[],"label_agreement":null},{"id":"W3214960410","doi":"10.1038/s41523-021-00346-1","title":"The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group","year":2021,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Université de Montréal; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council; National Cancer Institute; Cancer Research UK; National Institutes of Health; National Breast Cancer Foundation; National Center for Advancing Translational Sciences; Royal Australasian College of Physicians; National Health and Medical Research Council; Breast Cancer Research Foundation","keywords":"Oncology; Immunotherapy; Breast cancer; Medicine; Tumor-infiltrating lymphocytes; Biomarker; Internal medicine; Immune checkpoint; Cancer; Clinical Oncology; Triple-negative breast cancer; Biology","score_opus":0.0420120292087145,"score_gpt":0.3629201689834325,"score_spread":0.320908139774718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214960410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024713392,0.9855031,0.0000035623355,0.0070651053,0.0036886132,0.0008395672,0.0011534379,0.000024583276,0.0014749457],"genre_scores_gemma":[0.0010096721,0.99493915,0.000025754465,0.00060280313,0.0013810046,0.000868212,0.00040433652,0.00008106471,0.0006879854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656177,0.0002817235,0.0014059797,0.0006670422,0.000628764,0.00045471662],"domain_scores_gemma":[0.9969824,0.00059154636,0.0011718295,0.0009446556,0.00023424122,0.00007532675],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009708207,0.00048434242,0.0016840657,0.00013120976,0.00013988104,0.00007568312,0.0007596745,0.00043098777,0.0024906357],"category_scores_gemma":[0.000036122663,0.00027157707,0.0008686139,0.00072391354,0.00041301374,0.00006848116,0.00024647848,0.00066721055,0.000005406652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093490665,0.00012651477,0.0043784883,0.00043097025,0.0024806159,0.00025790645,0.00011122405,2.3857635e-7,0.00010985026,0.000009550591,0.010180517,0.9809792],"study_design_scores_gemma":[0.0012696711,0.000015570587,0.024623044,0.024153752,0.0007678755,0.003475751,0.0001428819,0.0000060413836,0.000003549756,0.0000065978143,0.94527453,0.00026075545],"about_ca_topic_score_codex":0.019995965,"about_ca_topic_score_gemma":0.005664071,"teacher_disagreement_score":0.98071843,"about_ca_system_score_codex":0.0019925372,"about_ca_system_score_gemma":0.0028571426,"threshold_uncertainty_score":0.99997365},"labels":[],"label_agreement":null},{"id":"W3215126804","doi":"10.1038/s41523-021-00355-0","title":"Acupuncture versus cognitive behavioral therapy for pain among cancer survivors with insomnia: an exploratory analysis of a randomized clinical trial","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Sleep and related disorders","field":"Psychology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"H2020 European Research Council; National Cancer Institute; National Institutes of Health; Memorial Sloan-Kettering Cancer Center; Patient-Centered Outcomes Research Institute","keywords":"Insomnia; Medicine; Acupuncture; Randomized controlled trial; Physical therapy; Cancer pain; Quality of life (healthcare); Cognitive behavioral therapy for insomnia; Cognitive behavioral therapy; Internal medicine; Cancer; Psychiatry; Alternative medicine","score_opus":0.059138803911797454,"score_gpt":0.40631886022434943,"score_spread":0.347180056312552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215126804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911533,0.0028373548,0.00097513956,0.00021471748,0.0023522268,0.0015363325,0.0006747313,0.000050025435,0.0002061502],"genre_scores_gemma":[0.9952656,0.0008218336,0.000037466954,0.00040126703,0.0004180259,0.0025630593,0.00027702964,0.000056776822,0.00015891295],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9958615,0.0021316684,0.0006837694,0.00066416356,0.0002920325,0.00036689304],"domain_scores_gemma":[0.9968776,0.0015391579,0.0004246449,0.00035864866,0.00063210534,0.00016785695],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016418626,0.00034079963,0.0015642662,0.00020470018,0.00008841417,0.00002546524,0.00015929555,0.0004666133,0.0034089817],"category_scores_gemma":[0.00010621132,0.00021113914,0.00094506127,0.00090719154,0.0005120484,0.00012733504,0.000018550387,0.00035381288,0.0000020559683],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8254928,0.0019288207,0.06501187,0.0000063092457,0.023608085,0.00001916958,0.004287756,0.00012210547,0.000008945891,0.0000222585,0.0002717789,0.07922012],"study_design_scores_gemma":[0.9387347,0.0010381711,0.031371187,0.00006237951,0.017404364,0.0000014726744,0.010311455,0.0002794912,0.00002636377,0.0000137972465,0.00033403703,0.00042254032],"about_ca_topic_score_codex":0.005433142,"about_ca_topic_score_gemma":0.037910137,"teacher_disagreement_score":0.113241956,"about_ca_system_score_codex":0.000056300632,"about_ca_system_score_gemma":0.00038579915,"threshold_uncertainty_score":0.997502},"labels":[],"label_agreement":null},{"id":"W3216265150","doi":"10.1038/s41523-021-00354-1","title":"Mammographic texture features associated with contralateral breast cancer in the WECARE Study","year":2021,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Lunenfeld-Tanenbaum Research Institute","funders":"National Institute of Allergy and Infectious Diseases; U.S. Department of Health and Human Services; Cancer Australia; National Cancer Institute; Cure Cancer Australia Foundation; Cancer Council Victoria","keywords":"Medicine; Breast cancer; Confounding; MAMMOGRAPHIC DENSITY; Mammography; Texture (cosmology); Odds ratio; Cancer; Internal medicine; Artificial intelligence; Computer science; Image (mathematics)","score_opus":0.005498334503839506,"score_gpt":0.2790828574298052,"score_spread":0.2735845229259657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216265150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95305103,0.0019263907,0.0000061780747,0.043264765,0.00026896817,0.00048411175,0.00022243094,0.000059253285,0.0007168511],"genre_scores_gemma":[0.993269,0.000146892,0.00001277849,0.0050731674,0.00045246852,0.00015116883,0.000046042536,0.00004121269,0.00080721686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981421,0.00021259373,0.00021869366,0.00040889607,0.0005691623,0.00044853406],"domain_scores_gemma":[0.9991424,0.00007208497,0.0000938783,0.0003129904,0.00023769958,0.00014094617],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00030208286,0.00024407737,0.00042368865,0.000092209746,0.00012761174,0.00008786909,0.00017464657,0.00010980582,0.0009273839],"category_scores_gemma":[0.000040967232,0.00014165309,0.00009861149,0.0006673534,0.0001207641,0.00007754291,0.00003378336,0.0010739755,0.000002176369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026358428,0.00041640562,0.9652628,0.000032541007,0.00033905197,0.0008917378,0.0015119504,0.00014095062,0.00021447583,0.00001818233,0.0024713536,0.028436987],"study_design_scores_gemma":[0.003924441,0.00006566607,0.9915071,0.00060236914,0.0002775823,0.0011831553,0.0012384251,0.00035405369,0.00000685254,0.000013275757,0.00064195425,0.00018513651],"about_ca_topic_score_codex":0.0032304365,"about_ca_topic_score_gemma":0.0048410962,"teacher_disagreement_score":0.040218,"about_ca_system_score_codex":0.00016842142,"about_ca_system_score_gemma":0.00033283318,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W4220913811","doi":"10.1038/s41523-022-00405-1","title":"Associations with response to Poly(ADP-ribose) Polymerase (PARP) inhibitors in patients with metastatic breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Breast Cancer Foundation","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Hazard ratio; BRCA mutation; Chemotherapy; Metastatic breast cancer; PARP inhibitor; Cancer; Olaparib; Proportional hazards model; Meta-analysis; Clinical trial; Poly ADP ribose polymerase; Confidence interval; Polymerase; Biology","score_opus":0.010978979176223775,"score_gpt":0.28127023104745524,"score_spread":0.2702912518712315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220913811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95547676,0.00049874804,0.000042430864,0.031109689,0.00045485666,0.0014321455,0.010633892,0.00012370679,0.00022778838],"genre_scores_gemma":[0.9891888,0.000015260759,0.00025746363,0.006695458,0.00036556905,0.0022706278,0.00016949547,0.00013119909,0.00090615073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962736,0.0003594744,0.00052801846,0.0007176863,0.0013877882,0.00073345477],"domain_scores_gemma":[0.9982226,0.00011751044,0.00031694898,0.00054193067,0.00036826901,0.0004327674],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00043810284,0.00041862662,0.00063697185,0.0005548552,0.0003365085,0.00004176187,0.00020244473,0.000061126666,0.0043487228],"category_scores_gemma":[0.000020032665,0.00035528975,0.00009651558,0.00176905,0.000117133255,0.0002481443,0.000093694696,0.0005666524,0.000023698844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041485317,0.0013063423,0.92984265,0.000038944825,0.000497415,0.00008995636,0.0017023843,0.0013973729,0.0014494825,0.000019989688,0.008869164,0.013300976],"study_design_scores_gemma":[0.013611779,0.0007098645,0.97834104,0.00035941516,0.00021418148,0.00012723121,0.00032593613,0.00002754997,0.00069415435,0.0000087141,0.0050635487,0.0005165925],"about_ca_topic_score_codex":0.006698012,"about_ca_topic_score_gemma":0.0013305618,"teacher_disagreement_score":0.048498377,"about_ca_system_score_codex":0.0038183166,"about_ca_system_score_gemma":0.0016906274,"threshold_uncertainty_score":0.9999165},"labels":[],"label_agreement":null},{"id":"W4225270990","doi":"10.1038/s41523-022-00425-x","title":"Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Health and Medical Research Council; Cancer Research UK; BC Cancer Agency; QIMR Berghofer Medical Research Institute; Metro North Hospital and Health Service; Department of Foreign Affairs and Trade, Australian Government; Cancer Research Institute","keywords":"SOX10; Biology; Triple-negative breast cancer; Reprogramming; Cancer research; Breast cancer; Phenotype; Neural crest; Genetics; Cancer; Gene","score_opus":0.009202576760837917,"score_gpt":0.257375750146791,"score_spread":0.24817317338595307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225270990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903863,0.0064229234,0.00005778367,0.0011918122,0.00041336712,0.00031586358,0.0010150863,0.000010977168,0.00018588282],"genre_scores_gemma":[0.99711597,0.0012946359,0.00007028427,0.00039834328,0.00036396764,0.00026557402,0.00010007357,0.000037657654,0.00035348683],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99856484,0.00014159804,0.00024538464,0.00051695615,0.00019375813,0.00033744387],"domain_scores_gemma":[0.9994334,0.00001628107,0.00012817177,0.0002278255,0.000085659354,0.00010869364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016085882,0.00021149399,0.00020344359,0.00008408187,0.00021459562,0.000027417871,0.00016294452,0.000098827055,0.00044251906],"category_scores_gemma":[0.000009593475,0.00021665159,0.000063707004,0.00018648947,0.0000921027,0.000009918483,0.00024139891,0.00022230725,0.0000018680089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075441116,0.00013825535,0.2562573,0.00003201303,0.000055636923,0.0000075218177,0.00043303947,0.004360597,0.7032164,0.000035217792,0.0002813061,0.034428347],"study_design_scores_gemma":[0.0017041832,0.000120394674,0.97767293,0.000021981452,0.000030594794,0.000018882045,0.0001849353,0.00068241765,0.016898269,0.00021902914,0.0020768745,0.0003694858],"about_ca_topic_score_codex":0.0036169775,"about_ca_topic_score_gemma":0.0023031912,"teacher_disagreement_score":0.72141564,"about_ca_system_score_codex":0.00014350828,"about_ca_system_score_gemma":0.00016383645,"threshold_uncertainty_score":0.88347954},"labels":[],"label_agreement":null},{"id":"W4281762255","doi":"10.1038/s41523-022-00435-9","title":"Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancer Research UK Cambridge Institute, University of Cambridge; NIHR Cambridge Biomedical Research Centre; BC Cancer Agency; Fundação para a Ciência e a Tecnologia; Centro de Investigação em Biomedicina; Centro de Investigação em Tecnologias e Serviços de Saúde; European Commission; National Institute for Health and Care Research; University of Cambridge; Cancer Research UK","keywords":"Allele; Breast cancer; Missense mutation; Cancer research; Mutant; Gene; Biology; Estrogen receptor; Cancer; Medicine; Oncology; Genetics; Mutation","score_opus":0.0084076767347095,"score_gpt":0.26466906326024414,"score_spread":0.25626138652553465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281762255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898222,0.0033767514,0.00013861814,0.0030566517,0.0002807893,0.00039115097,0.0027047498,0.000017027598,0.00021208072],"genre_scores_gemma":[0.9971333,0.0005788541,0.00024556316,0.00074649916,0.00020716162,0.0008118282,0.00006755904,0.000037669754,0.00017156544],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99839795,0.000081005644,0.00032956243,0.0005375019,0.00032124217,0.00033273513],"domain_scores_gemma":[0.9992538,0.00002274098,0.00016644143,0.00030275673,0.0001445324,0.000109720524],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00015858225,0.00020199319,0.0002327874,0.00006901823,0.000111373585,0.000015862943,0.00024688625,0.00009443924,0.000940415],"category_scores_gemma":[0.000013156648,0.00020108982,0.00006729108,0.00018696669,0.00015601331,0.000009050414,0.00020965215,0.00020215787,0.0000012915466],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034414858,0.00017499033,0.1526693,0.000069235095,0.000060307873,0.000008477294,0.00024336424,0.0018163723,0.83508414,0.00002929118,0.0029721202,0.006528286],"study_design_scores_gemma":[0.0034423298,0.00034579888,0.7413154,0.00041312753,0.00011000487,0.00022011796,0.0004276928,0.0009718638,0.23590007,0.00027044574,0.015589338,0.0009937763],"about_ca_topic_score_codex":0.001235608,"about_ca_topic_score_gemma":0.00013451802,"teacher_disagreement_score":0.59918404,"about_ca_system_score_codex":0.00014976616,"about_ca_system_score_gemma":0.00041459675,"threshold_uncertainty_score":0.9999729},"labels":[],"label_agreement":null},{"id":"W4283775775","doi":"10.1038/s41523-022-00442-w","title":"The different prognostic significance of polysialic acid and CD56 expression in tumor cells and lymphocytes identified in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"Congressionally Directed Medical Research Programs; Canadian Glycomics Network; Networks of Centres of Excellence of Canada; Michael Smith Health Research BC; Susan G. Komen; Government of Canada; U.S. Department of Defense","keywords":"Polysialic acid; Breast cancer; Cancer research; Cancer; Medicine; Internal medicine; Oncology; Biology; Cell; Neural cell adhesion molecule; Genetics; Cell adhesion","score_opus":0.007499917206947022,"score_gpt":0.25585511794032423,"score_spread":0.24835520073337722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283775775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99434537,0.0041193734,0.000007945901,0.00060570845,0.0000905997,0.0004286872,0.0003598232,0.000003513186,0.000038953447],"genre_scores_gemma":[0.9977856,0.0011673907,0.000009579249,0.00007081498,0.000054443626,0.0006828529,0.000014647019,0.000014902079,0.00019972172],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99882394,0.00015203767,0.00021515781,0.00032351058,0.00023439233,0.00025094926],"domain_scores_gemma":[0.9995893,0.00002202733,0.00008888524,0.00018576326,0.000048878712,0.00006511434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017727156,0.00012687923,0.00015349872,0.00006800341,0.00012566027,0.000029891731,0.00015468651,0.000040426043,0.00013923946],"category_scores_gemma":[0.000011118743,0.00009644821,0.000028315264,0.00015367287,0.00012484867,0.0000066495672,0.0002404619,0.00012510984,3.0818987e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005490045,0.00006532926,0.12045596,0.000046266658,0.000011207885,0.0000043715595,0.000085247455,0.00010669326,0.867384,0.0000096679305,0.00014407044,0.011138157],"study_design_scores_gemma":[0.0014916058,0.000052385803,0.6202901,0.000076314696,0.000007782301,0.000037170565,0.0003956362,0.00047607927,0.37603745,0.00004062394,0.0009276289,0.00016721828],"about_ca_topic_score_codex":0.0014832426,"about_ca_topic_score_gemma":0.0012670547,"teacher_disagreement_score":0.49983415,"about_ca_system_score_codex":0.00008660821,"about_ca_system_score_gemma":0.00016004579,"threshold_uncertainty_score":0.39330438},"labels":[],"label_agreement":null},{"id":"W4285992942","doi":"10.1038/s41523-022-00452-8","title":"PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Charles-Le Moyne; Université de Sherbrooke","funders":"Novartis Pharma; National Cancer Institute; National Institutes of Health; Amis de l'Institut Bordet; Ministero della Salute; Associazione Italiana per la Ricerca sul Cancro; National Institute for Health and Care Research; American Society of Clinical Oncology; GlaxoSmithKline","keywords":"Lapatinib; Trastuzumab; Medicine; Internal medicine; Breast cancer; Oncology; Stage (stratigraphy); Chemotherapy; Population; Cancer","score_opus":0.019051291407503723,"score_gpt":0.31597203856608413,"score_spread":0.2969207471585804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285992942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728263,0.0004399906,0.000038300164,0.0034510868,0.000522977,0.0012039033,0.019059133,0.0001034582,0.002354852],"genre_scores_gemma":[0.9967354,0.000096924,0.000067898385,0.00031216413,0.00028624004,0.00070419256,0.00016071717,0.00011725904,0.0015191885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996254,0.00017968997,0.00038282963,0.0006111551,0.0018588692,0.00071341265],"domain_scores_gemma":[0.9981393,0.00009483608,0.00021154033,0.00053029,0.000676628,0.0003473873],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00028120895,0.00032510658,0.0005813064,0.00018589738,0.00023656718,0.000029104871,0.00033016893,0.00008393777,0.014462773],"category_scores_gemma":[0.000013820256,0.00027330246,0.000114519695,0.00065811374,0.00034324647,0.00014965495,0.00028798755,0.0006678763,0.000013725577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004023259,0.000576176,0.9828213,0.00029963756,0.000390787,0.000049837574,0.0004317662,0.00075535546,0.00017086235,0.00005980349,0.0022116909,0.008209558],"study_design_scores_gemma":[0.0035400377,0.00059030624,0.99214906,0.00037648802,0.0001525704,0.000045877423,0.00025265958,0.00024272053,0.00032843841,0.000011862065,0.0020286967,0.0002812692],"about_ca_topic_score_codex":0.021826698,"about_ca_topic_score_gemma":0.0010243643,"teacher_disagreement_score":0.023909118,"about_ca_system_score_codex":0.0014006819,"about_ca_system_score_gemma":0.0014513774,"threshold_uncertainty_score":0.9999719},"labels":[],"label_agreement":null},{"id":"W4293047601","doi":"10.1038/s41523-022-00458-2","title":"MRI background parenchymal enhancement, breast density and breast cancer risk factors: A cross-sectional study in pre- and post-menopausal women","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Government of Canada; U.S. Department of Health and Human Services","keywords":"Breast cancer; Medicine; Tamoxifen; Body mass index; Breast MRI; Cancer; Poisson regression; Magnetic resonance imaging; Cross-sectional study; Confidence interval; Risk factor; Oncology; Gynecology; Internal medicine; Radiology; Mammography; Population; Pathology","score_opus":0.018370807905552972,"score_gpt":0.3159501581145901,"score_spread":0.29757935020903714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293047601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968965,0.00080581097,0.0000075924886,0.0012271159,0.00072091183,0.0014244356,0.005968905,0.00007542551,0.00008018389],"genre_scores_gemma":[0.994826,0.0008689845,0.000024255793,0.0004981849,0.00060346,0.0025474783,0.000069880596,0.000076631186,0.00048509391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959204,0.00024990973,0.0006530848,0.0012664624,0.0010235136,0.0008866092],"domain_scores_gemma":[0.9982615,0.00014348143,0.00032150754,0.0004809865,0.00031423182,0.00047825513],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00067428435,0.0005269937,0.0007230384,0.0002815711,0.00056836253,0.00016331358,0.00021795616,0.00013233381,0.009273547],"category_scores_gemma":[0.000010193648,0.0005110253,0.00005486821,0.00051339925,0.0002853201,0.00039647444,0.0005323687,0.0008800356,0.000005998252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030253795,0.0012333165,0.98624015,0.00012867538,0.00046487944,0.00004493168,0.00335711,0.000162165,0.0013964183,0.000004977277,0.0004963738,0.0034456071],"study_design_scores_gemma":[0.005136712,0.00087924773,0.9898278,0.00008464101,0.00018544435,0.0011164059,0.0017054892,0.00010356409,0.00006205274,0.000021780827,0.00038305135,0.0004937853],"about_ca_topic_score_codex":0.07562532,"about_ca_topic_score_gemma":0.0073185023,"teacher_disagreement_score":0.06830682,"about_ca_system_score_codex":0.0031394057,"about_ca_system_score_gemma":0.0007198508,"threshold_uncertainty_score":0.99973416},"labels":[],"label_agreement":null},{"id":"W4308569225","doi":"10.1038/s41523-022-00488-w","title":"Deep learning for fully-automated nuclear pleomorphism scoring in breast cancer","year":2022,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"AI in cancer detection","field":"Computer Science","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Innovative Medicines Initiative; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; European Commission; Puma Biotechnology; AstraZeneca; Myriad Genetics; European Federation of Pharmaceutical Industries and Associations; Daiichi Sankyo Europe; Horizon 2020 Framework Programme; Knut och Alice Wallenbergs Stiftelse; Bristol-Myers Squibb","keywords":"Pleomorphism (cytology); Grading (engineering); Breast cancer; Limiting; Artificial intelligence; Pathology; Radiology; Medicine; Computer science; Cancer; Biology; Internal medicine","score_opus":0.011400631360581837,"score_gpt":0.2521539765656102,"score_spread":0.2407533452050284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308569225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7197241,0.0060831127,0.16722219,0.0605809,0.025225688,0.0051918095,0.0010504315,0.011671448,0.0032503128],"genre_scores_gemma":[0.9955524,0.000106526895,0.001568302,0.00080910523,0.0004559624,0.0012747358,0.0000058260844,0.00007509015,0.0001520437],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99747944,0.00013767587,0.00036181742,0.00079682015,0.0005379091,0.0006863139],"domain_scores_gemma":[0.99898434,0.000066457906,0.0002413469,0.00043334486,0.00014587419,0.00012861802],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00039349968,0.00026445067,0.00030473826,0.00027751166,0.00064029894,0.00014475631,0.00091863086,0.0000807274,0.0012988144],"category_scores_gemma":[0.000008550864,0.0003062592,0.000111329,0.0010110902,0.000054106848,0.00062314566,0.0005458546,0.0005777587,0.000018319293],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000499545,0.00016041486,0.034224834,0.0001361543,0.00011367424,0.000045252753,0.0025974778,0.40574035,0.0047973194,0.0013920218,0.0037017332,0.5465912],"study_design_scores_gemma":[0.0014460909,0.00007563707,0.13436475,0.000091073685,0.00001886122,0.000379961,0.00018444168,0.8485293,0.00012737888,0.0001787062,0.014113575,0.00049025257],"about_ca_topic_score_codex":0.004707742,"about_ca_topic_score_gemma":0.00060472783,"teacher_disagreement_score":0.546101,"about_ca_system_score_codex":0.002060749,"about_ca_system_score_gemma":0.00027994084,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W4376630874","doi":"10.1038/s41523-023-00546-x","title":"PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants","year":2023,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Syöpäsäätiö; European Commission; Fondation du cancer du sein du Québec; National Cancer Institute; National Institutes of Health; Cancer Research UK; Government of Canada; Wellcome Trust; Canadian Institutes of Health Research; Sigrid Juséliuksen Säätiö; Genome Canada","keywords":"Breast cancer; Oncology; Internal medicine; Medicine; Cancer","score_opus":0.015006743225559852,"score_gpt":0.26973631242294754,"score_spread":0.2547295691973877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376630874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813305,0.00026114305,0.00035482418,0.0006749845,0.000607369,0.00091790466,0.015694866,0.00005063883,0.00010775316],"genre_scores_gemma":[0.9961824,0.00023309999,0.00033424783,0.00016257452,0.000567777,0.0016099311,0.00055048655,0.0000766491,0.00028285617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835294,0.000046779325,0.00029190734,0.0005720899,0.00031190075,0.00042439153],"domain_scores_gemma":[0.99862707,0.00001978732,0.00020991197,0.00038509216,0.0006492091,0.00010890842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016307067,0.00024319714,0.0002459876,0.00007869887,0.00010899883,0.000019776804,0.00027264128,0.00017225705,0.0002097378],"category_scores_gemma":[0.000019408895,0.00021229347,0.0001260881,0.00038369157,0.00012751858,0.000013146854,0.00010460276,0.000079176425,0.000006048282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012440467,0.00033799195,0.8909938,0.00026683416,0.0006660571,0.0000015066313,0.00013025876,0.0012181198,0.04313736,0.0000162538,0.023352785,0.038635023],"study_design_scores_gemma":[0.0021210671,0.00020256697,0.98024166,0.00010310909,0.00017930882,0.0000114858485,0.000027113383,0.00019326087,0.013168896,0.000030964235,0.0034098548,0.0003107467],"about_ca_topic_score_codex":0.0002302352,"about_ca_topic_score_gemma":0.0002532357,"teacher_disagreement_score":0.08924787,"about_ca_system_score_codex":0.00015033252,"about_ca_system_score_gemma":0.00068537705,"threshold_uncertainty_score":0.86570764},"labels":[],"label_agreement":null},{"id":"W4389733405","doi":"10.1038/s41523-023-00591-6","title":"Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer","year":2023,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Hamilton Health Sciences; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"National Institutes of Health","keywords":"Medicine; Breast cancer; Adjuvant; Adjuvant therapy; Oncology; Internal medicine; Stage (stratigraphy); Clinical trial; Radiation therapy; Incidence (geometry); Disease; Cancer; Gynecology","score_opus":0.006606687996877802,"score_gpt":0.25102714783786995,"score_spread":0.24442045984099214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389733405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958419,0.0009926816,0.000010304922,0.0004134632,0.00016242916,0.0003365248,0.002095428,0.000042857566,0.000104363644],"genre_scores_gemma":[0.99284184,0.0052197454,0.000049021994,0.0001683045,0.00029684464,0.0007152195,0.00005393638,0.00008104361,0.00057406526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809694,0.00006402723,0.0002758298,0.0006111235,0.0003029012,0.00064916327],"domain_scores_gemma":[0.99911076,0.00001662429,0.00018021118,0.0004374278,0.00013069338,0.00012431017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013634123,0.00032872366,0.00042003545,0.000121552905,0.00006513725,0.000021002554,0.0002464147,0.00014788826,0.00036411177],"category_scores_gemma":[0.0000040547266,0.00028157647,0.0000873329,0.0004552203,0.0002236262,0.000014674574,0.00013481428,0.00016258762,0.000015508589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00354335,0.00030916094,0.8742513,0.0000736748,0.0008127838,0.00009446621,0.0025007138,0.0039773984,0.011086728,0.000004831505,0.00094665546,0.10239893],"study_design_scores_gemma":[0.0034276755,0.00014594158,0.9911122,0.00013637739,0.000029642466,0.000022167504,0.00041276548,0.000021133796,0.0033108953,0.00000418263,0.0010405685,0.00033645908],"about_ca_topic_score_codex":0.009202368,"about_ca_topic_score_gemma":0.0020347661,"teacher_disagreement_score":0.11686089,"about_ca_system_score_codex":0.00019524638,"about_ca_system_score_gemma":0.00025566138,"threshold_uncertainty_score":0.99996364},"labels":[],"label_agreement":null},{"id":"W4390607200","doi":"10.1038/s41523-023-00607-1","title":"Circulating tumour mutation detection in triple-negative breast cancer as an adjunct to tissue response assessment","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC","funders":"BC Cancer Foundation; Canadian Institutes of Health Research; Susan G. Komen; Government of Canada; Breast Cancer Research Foundation","keywords":"Medicine; Breast cancer; Triple-negative breast cancer; Liquid biopsy; Oncology; Biopsy; Internal medicine; Neoadjuvant therapy; Circulating tumor DNA; Minimal residual disease; Pathology; Cancer","score_opus":0.008582745815151772,"score_gpt":0.3189100114348784,"score_spread":0.3103272656197266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390607200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935836,0.00058309094,0.0019770644,0.0015342683,0.0009180881,0.00046102641,0.00072603946,0.000028284452,0.00018854656],"genre_scores_gemma":[0.99746597,0.00015616624,0.00021223992,0.00054710225,0.0008657961,0.00042453696,0.00005122202,0.00005417217,0.00022279714],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99848944,0.00012784851,0.00026954134,0.00060419645,0.00019519626,0.0003137499],"domain_scores_gemma":[0.9993423,0.000047078174,0.00006601139,0.00022568491,0.00015541875,0.00016347817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032658156,0.0002186734,0.0001768145,0.00014957902,0.0000846234,0.00011289169,0.00012252388,0.00013690931,0.00021959645],"category_scores_gemma":[0.00005868976,0.00022839264,0.000060380833,0.00032802566,0.000031821488,0.000021132188,0.0000662227,0.00016552741,0.000017319599],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013145362,0.00006162329,0.0015366357,0.000042295724,0.000057233156,0.00007194654,0.00038342972,0.0063688853,0.8093375,0.000035744073,0.00026927845,0.18052089],"study_design_scores_gemma":[0.0017584116,0.000590459,0.74832875,0.00038146702,0.000093217845,0.0006637697,0.0005392332,0.007663199,0.23320092,0.00029635796,0.005677169,0.00080702984],"about_ca_topic_score_codex":0.007703719,"about_ca_topic_score_gemma":0.009325294,"teacher_disagreement_score":0.74679214,"about_ca_system_score_codex":0.0005803159,"about_ca_system_score_gemma":0.0007599364,"threshold_uncertainty_score":0.99890405},"labels":[],"label_agreement":null},{"id":"W4393318831","doi":"10.1038/s41523-024-00629-3","title":"Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health; George M. Eisenberg Foundation for Charities; Breast Cancer Research Foundation","keywords":"Medicine; Triple-negative breast cancer; Oncology; Internal medicine; Cohort; Breast cancer; Stage (stratigraphy); Cancer; Biology","score_opus":0.014489536226999,"score_gpt":0.3081748325583574,"score_spread":0.2936852963313584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393318831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894746,0.0018983519,0.000008283526,0.0015946904,0.0010052966,0.00053520506,0.004690466,0.0003157906,0.00047729243],"genre_scores_gemma":[0.996171,0.0004039722,0.000022975695,0.00027243522,0.00032077957,0.00032531805,0.00011345101,0.000087198874,0.0022828474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771327,0.00015893615,0.0004873209,0.0007929374,0.00032425037,0.00052330276],"domain_scores_gemma":[0.9989774,0.00008013737,0.00020314788,0.0003329095,0.0002620171,0.00014437959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016186235,0.00044411435,0.0006364062,0.00010876796,0.0000822351,0.00007264904,0.00021253388,0.0003234979,0.00023192617],"category_scores_gemma":[0.00004326855,0.00033467566,0.00017611783,0.00043454,0.00020937344,0.000019639263,0.000084982064,0.00027147823,0.000063042025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006631391,0.0002733685,0.9909696,0.00011399637,0.0019439984,0.00012420688,0.00010173869,0.000096477226,0.0003194168,0.000015732441,0.0039532324,0.0014250888],"study_design_scores_gemma":[0.0024226974,0.00007797058,0.99467593,0.0010669924,0.00023228394,0.000043427055,0.00006879769,0.0003012653,0.00022135484,0.0000045252373,0.00047054747,0.00041419076],"about_ca_topic_score_codex":0.0043839645,"about_ca_topic_score_gemma":0.0046362653,"teacher_disagreement_score":0.006696399,"about_ca_system_score_codex":0.0005149171,"about_ca_system_score_gemma":0.0004775085,"threshold_uncertainty_score":0.99991053},"labels":[],"label_agreement":null},{"id":"W4399806930","doi":"10.1038/s41523-024-00653-3","title":"Use of ctDNA in early breast cancer: analytical validity and clinical potential","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Svenska Sällskapet för Medicinsk Forskning","keywords":"Breast cancer; Circulating tumor DNA; Medicine; Oncology; Internal medicine; Clinical trial; Cancer; Minimal residual disease; Clinical Practice; Family medicine","score_opus":0.027612222489792775,"score_gpt":0.3205653539150176,"score_spread":0.29295313142522483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399806930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99422187,0.0018142805,0.00011989593,0.0011143895,0.0006624631,0.00011827785,0.0018809172,0.000009275371,0.000058619218],"genre_scores_gemma":[0.9922293,0.006377064,0.000065476146,0.00021847317,0.0009035588,0.000019667059,0.000028462377,0.000026868833,0.00013115084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987662,0.00004864091,0.00035074147,0.00045432732,0.00013278086,0.00024732074],"domain_scores_gemma":[0.9994349,0.00004567356,0.00005435096,0.00023235612,0.00009354126,0.00013918562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016840013,0.00015678046,0.00024567792,0.000058444915,0.000024426703,0.000066578985,0.00010790523,0.00019324412,0.000108434775],"category_scores_gemma":[0.000026328771,0.00014874397,0.00013375458,0.0001234229,0.00018196924,0.000010587529,0.0001375425,0.0001714235,0.000002983728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071304035,0.00019579871,0.8986167,0.00012015129,0.000238362,0.000053215084,0.000041452786,0.000412798,0.011693599,0.00025664357,0.006542327,0.08111592],"study_design_scores_gemma":[0.0005873892,0.000106499145,0.9853953,0.00012338276,0.00013422774,0.000089061126,0.000008495196,0.0027903933,0.0010107092,0.000059740432,0.009451201,0.00024358416],"about_ca_topic_score_codex":0.0045611877,"about_ca_topic_score_gemma":0.0014030862,"teacher_disagreement_score":0.08677862,"about_ca_system_score_codex":0.00005404867,"about_ca_system_score_gemma":0.00034590747,"threshold_uncertainty_score":0.6895182},"labels":[],"label_agreement":null},{"id":"W4402494964","doi":"10.1038/s41523-024-00679-7","title":"Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC","year":2024,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"National Breast Cancer Foundation; Breast Cancer Research Foundation","keywords":"Pembrolizumab; Oncology; Medicine; Internal medicine; Chemotherapy; Randomized controlled trial; Immunotherapy; Cancer","score_opus":0.008130626764051447,"score_gpt":0.27269681275941676,"score_spread":0.2645661859953653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402494964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356164,0.0023171129,0.0001711635,0.006785038,0.00067169365,0.004439123,0.0013802991,0.00008932005,0.0005846266],"genre_scores_gemma":[0.99722683,0.00023702491,0.00013750826,0.0008879655,0.00032811536,0.00058811676,0.00011281582,0.000063363834,0.00041823197],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99830115,0.000079651465,0.0004895122,0.00044464524,0.00043022903,0.0002548303],"domain_scores_gemma":[0.9987448,0.00033710207,0.00017541742,0.00046845048,0.00021036017,0.000063908315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029061222,0.00025317914,0.0006805791,0.000061783896,0.00008140607,0.00003550354,0.00016261949,0.00007589122,0.0002512049],"category_scores_gemma":[0.000030134548,0.00013452153,0.00022883214,0.00026891282,0.00016063005,0.00009175974,0.000017059188,0.00015810186,0.0000023502414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79609656,0.00038572671,0.0011788341,0.00006573508,0.0016233115,0.0000048304305,0.0042622644,0.000021095384,0.00030025849,0.0000077380555,0.0022464804,0.19380715],"study_design_scores_gemma":[0.8057844,0.0011803115,0.1784491,0.0008398788,0.0006991841,0.000007966366,0.0010655369,0.00042070827,0.0004471594,0.000046078956,0.010775531,0.00028412385],"about_ca_topic_score_codex":0.0021519146,"about_ca_topic_score_gemma":0.0003851362,"teacher_disagreement_score":0.19352302,"about_ca_system_score_codex":0.00024766824,"about_ca_system_score_gemma":0.0003430797,"threshold_uncertainty_score":0.5485629},"labels":[],"label_agreement":null},{"id":"W4407538000","doi":"10.1038/s41523-025-00720-3","title":"A pooled analysis evaluating prognostic significance of Residual Cancer Burden in invasive lobular breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; U.S. Department of Health and Human Services","keywords":"Invasive lobular carcinoma; Breast cancer; Medicine; Oncology; Internal medicine; Proportional hazards model; Cancer; Cohort; Invasive ductal carcinoma","score_opus":0.013176440605504111,"score_gpt":0.3105113585715858,"score_spread":0.2973349179660817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407538000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975547,0.014916092,0.000106874475,0.0051601594,0.0003221991,0.0008575614,0.0026978643,0.000031104977,0.00036112402],"genre_scores_gemma":[0.9942925,0.0019615674,0.00017680005,0.00042920327,0.0004896462,0.002043297,0.00010816408,0.000045436616,0.00045339513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969861,0.00020903259,0.0006576315,0.0010361202,0.00046016497,0.00065094704],"domain_scores_gemma":[0.99814093,0.00009450836,0.00037256727,0.00060857163,0.0006744958,0.00010892577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002845245,0.00048197736,0.00080412766,0.0003654684,0.00013336296,0.000032640146,0.00042367945,0.00023360638,0.00042793286],"category_scores_gemma":[0.00009347767,0.00045769775,0.00026854253,0.0015599354,0.00027175958,0.000019117735,0.00026602545,0.0002075998,0.0000030308627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011385584,0.0002037248,0.8718108,0.00026121776,0.005706029,0.000011675959,0.00039428315,0.016716681,0.07549532,0.000025367544,0.0008528926,0.027383458],"study_design_scores_gemma":[0.0023324948,0.000056381465,0.9690461,0.00066458643,0.0032804932,0.0000101988435,0.00037397174,0.0003010283,0.02320916,0.00006152906,0.0001824476,0.00048159104],"about_ca_topic_score_codex":0.032895565,"about_ca_topic_score_gemma":0.02821388,"teacher_disagreement_score":0.09723533,"about_ca_system_score_codex":0.00049123855,"about_ca_system_score_gemma":0.0016572601,"threshold_uncertainty_score":0.99978745},"labels":[],"label_agreement":null},{"id":"W4407752195","doi":"10.1038/s41523-025-00733-y","title":"Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec; Queen's University","funders":"National Cancer Institute; National Medical Research Council; Canadian Institutes of Health Research; Deutsche Krebshilfe; National Institute of General Medical Sciences; National Institute for Health and Care Research; Bundesministerium für Bildung und Forschung; Government of Canada; Deutsche Forschungsgemeinschaft; Department of Health and Social Care; Canadian Cancer Society Research Institute; National Institutes of Health; Ovarian Cancer Research Fund; Fondation du cancer du sein du Québec; Genome Canada; Cancer Research UK; NIHR Cambridge Biomedical Research Centre; European Commission; Breast Cancer Research Foundation","keywords":"Aromatase inhibitor; Aromatase; Breast cancer; Oncology; Medicine; Internal medicine; Cancer; Gene; Bioinformatics; Cancer research; Biology; Genetics","score_opus":0.022577436593291242,"score_gpt":0.32725739991027936,"score_spread":0.3046799633169881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407752195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904862,0.00291961,0.000006081236,0.0037493997,0.00036277805,0.0005028241,0.0018383045,0.00002951566,0.000105303356],"genre_scores_gemma":[0.9972111,0.0007723744,0.0000517631,0.00044772823,0.0003245047,0.00046507083,0.0002583347,0.00003536675,0.00043375776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828964,0.00014120714,0.00035143085,0.0006699791,0.00014550632,0.0004022151],"domain_scores_gemma":[0.9992342,0.000016932381,0.00011223366,0.00043237416,0.000052592382,0.00015165722],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00011156274,0.000325938,0.00035337792,0.00009475191,0.0001242522,0.000045100434,0.00018354849,0.00021881315,0.00006518486],"category_scores_gemma":[0.000011494219,0.00027152398,0.000105012135,0.00024789505,0.00007912882,0.000008925446,0.0001342722,0.00020084037,0.000010373491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037083615,0.00048258362,0.6624917,0.000018626604,0.0004720781,0.000046690886,0.00022266738,0.00043460444,0.30363718,0.000005935441,0.00066972873,0.03114739],"study_design_scores_gemma":[0.008143947,0.00024687167,0.8535644,0.00032523958,0.00037422386,0.000037415615,0.0004407616,0.00033176856,0.13427109,0.000069816495,0.0014961276,0.0006983574],"about_ca_topic_score_codex":0.025425471,"about_ca_topic_score_gemma":0.0037968021,"teacher_disagreement_score":0.19107272,"about_ca_system_score_codex":0.00027894208,"about_ca_system_score_gemma":0.00042989515,"threshold_uncertainty_score":0.9999737},"labels":[],"label_agreement":null},{"id":"W4408279570","doi":"10.1038/s41523-025-00738-7","title":"Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; University of British Columbia","funders":"","keywords":"Anthracycline; Medicine; Epirubicin; Internal medicine; Oncology; Cyclophosphamide; Breast cancer; Regimen; Chemotherapy; Cancer","score_opus":0.005124689768412764,"score_gpt":0.2407062181391821,"score_spread":0.23558152837076934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408279570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848015,0.009185388,0.000024097017,0.0014014957,0.0001656566,0.0004039228,0.0039582993,0.000021183056,0.000038461014],"genre_scores_gemma":[0.98232543,0.016818006,0.000060529335,0.00019384378,0.00013627032,0.00027007508,0.00007198416,0.00003537014,0.00008851352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835294,0.0000755822,0.00033184228,0.0006717244,0.00019144437,0.0003764659],"domain_scores_gemma":[0.9987635,0.00003982819,0.00045150775,0.00034308108,0.00033151018,0.00007054437],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014364716,0.0003614924,0.0005429239,0.00010742168,0.00011855386,0.00001891822,0.00017503808,0.0001793623,0.000050780673],"category_scores_gemma":[0.000032677282,0.00028885127,0.00006618036,0.0004220863,0.00030625932,0.000015326585,0.000110610556,0.00021376276,5.433388e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015112107,0.00025028462,0.90645677,0.00006357906,0.00058659835,0.0000026868013,0.000097539516,0.00014967774,0.0013587076,0.00001272422,0.00021762923,0.089292586],"study_design_scores_gemma":[0.0039947266,0.00009166502,0.9862039,0.0010371164,0.00023411948,0.00001153844,0.00008063036,0.00003208594,0.007832937,0.00009394006,0.00009292192,0.00029441545],"about_ca_topic_score_codex":0.01062328,"about_ca_topic_score_gemma":0.022276402,"teacher_disagreement_score":0.08899817,"about_ca_system_score_codex":0.00017598209,"about_ca_system_score_gemma":0.00025153064,"threshold_uncertainty_score":0.99995637},"labels":[],"label_agreement":null},{"id":"W4409785972","doi":"10.1038/s41523-025-00754-7","title":"Body composition metrics as a determinant of trastuzumab deruxtecan related toxicity and response","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Memorial University of Newfoundland","funders":"","keywords":"Trastuzumab; Toxicity; Composition (language); Chemistry; Internal medicine; Medicine; Cancer; Breast cancer; Art","score_opus":0.007939468048927175,"score_gpt":0.29222461543254774,"score_spread":0.28428514738362054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409785972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99322486,0.0007683197,0.00020613163,0.0035801143,0.0001871194,0.00033336718,0.000034399374,0.000042153082,0.0016235574],"genre_scores_gemma":[0.9971648,0.00018936396,0.00014757212,0.0005652528,0.000026372607,0.000026066864,0.000007743428,0.000010641797,0.0018622056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990557,0.000054276643,0.00027389845,0.00022510011,0.00020930203,0.00018174457],"domain_scores_gemma":[0.9994404,0.00009113089,0.000099047815,0.0001923625,0.00010275311,0.000074310956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023026255,0.00013047761,0.00032187378,0.00037010855,0.000059208738,0.000013275614,0.00006286892,0.00007527444,0.00016837193],"category_scores_gemma":[0.00004373216,0.00011432061,0.000074087766,0.0006626415,0.0000841129,0.00006150477,0.000055988527,0.00012530449,0.0000026718633],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01784767,0.00076025457,0.45809713,0.00092019874,0.00083508866,0.00017526334,0.00083134574,0.00001769751,0.051813245,0.0010059682,0.004000757,0.46369538],"study_design_scores_gemma":[0.0033046443,0.00022707379,0.98676765,0.00031164175,0.00040931298,0.00010144157,0.0001182745,0.00030888678,0.0068632015,0.0001323279,0.001351538,0.00010397964],"about_ca_topic_score_codex":0.0005703981,"about_ca_topic_score_gemma":0.000041491017,"teacher_disagreement_score":0.52867055,"about_ca_system_score_codex":0.0003003919,"about_ca_system_score_gemma":0.00020292457,"threshold_uncertainty_score":0.46618593},"labels":[],"label_agreement":null},{"id":"W4410708732","doi":"10.1038/s41523-025-00759-2","title":"Treatment patterns and clinical outcomes of patients with HER2-positive T1micN0 breast cancer: a single-center analysis","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Single Center; Breast cancer; Medicine; Oncology; Internal medicine; Center (category theory); Cancer","score_opus":0.024748921851020744,"score_gpt":0.37959586164959996,"score_spread":0.35484693979857923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410708732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853172,0.00019413323,0.00007539154,0.0066589788,0.00018578014,0.00084732915,0.00616593,0.000032417574,0.00052288815],"genre_scores_gemma":[0.9973988,0.00053177436,0.00006845611,0.0008124353,0.000101927406,0.00022140212,0.000118858996,0.000034775476,0.0007115488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767727,0.00012658877,0.00054912904,0.00063689775,0.0005613535,0.00044879006],"domain_scores_gemma":[0.99834394,0.00014495557,0.00018200143,0.0004858705,0.000573195,0.00027001405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012320488,0.0003165066,0.0010226488,0.00032050774,0.00006871424,0.000030892166,0.00013233192,0.0001375116,0.0009332304],"category_scores_gemma":[0.000012976164,0.00021534969,0.0002984448,0.0006694959,0.00026965488,0.00008058566,0.000094522016,0.00023172681,0.0000033597196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017874253,0.001653276,0.8807208,0.00010284373,0.0054615405,0.000016889295,0.000119940094,0.00000733718,0.0000063273455,0.0000045089887,0.00022781595,0.10989132],"study_design_scores_gemma":[0.0064944318,0.0005354388,0.9890688,0.00047779627,0.002399108,0.000011862135,0.000078049015,0.00008272759,0.00007204658,0.0000018283339,0.0006012219,0.00017667156],"about_ca_topic_score_codex":0.027855523,"about_ca_topic_score_gemma":0.012039429,"teacher_disagreement_score":0.10971465,"about_ca_system_score_codex":0.0010825326,"about_ca_system_score_gemma":0.00061202666,"threshold_uncertainty_score":0.99998003},"labels":[],"label_agreement":null},{"id":"W4410850753","doi":"10.1038/s41523-025-00762-7","title":"A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study)","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa; Thunder Bay Regional Health Sciences Centre; Ottawa Hospital","funders":"Ottawa Hospital Foundation; Northern Ontario Academic Medicine Association; Ottawa Hospital Research Institute","keywords":"Evening; Morning; Randomized controlled trial; Dosing; Adjuvant; Medicine; Adjuvant therapy; Internal medicine; Cancer","score_opus":0.033985883043951066,"score_gpt":0.3307048067688537,"score_spread":0.29671892372490266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410850753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038094,0.0011648352,0.00022997014,0.00018739402,0.002306285,0.0022500653,0.000023588436,0.00008985648,0.0033670866],"genre_scores_gemma":[0.99879044,0.00020612493,0.000098413184,0.000109790475,0.00023201403,0.00035378843,0.000001986147,0.000028177083,0.00017924493],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99757266,0.00045493702,0.0006719617,0.00049938523,0.0003663183,0.00043470785],"domain_scores_gemma":[0.99811035,0.0010097263,0.00036375434,0.0003515302,0.00007138068,0.00009326315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005018047,0.0002685121,0.0009391726,0.00021496047,0.00017949403,0.00006473937,0.0002527541,0.000047797355,0.00018424894],"category_scores_gemma":[0.00038607718,0.00023174076,0.00022558292,0.0003547699,0.00015811843,0.00020974403,0.00010517266,0.00029189987,0.00000831245],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8912822,0.0008103786,0.005466357,0.00007576106,0.00022688477,0.000035758494,0.002246569,0.00081392133,0.05631214,0.0009217579,0.000049736158,0.041758537],"study_design_scores_gemma":[0.9335847,0.00010704194,0.0055862125,0.00038258758,0.0001526567,0.0000138555115,0.0002506525,0.0075738356,0.051583864,0.000012863234,0.0005124609,0.00023925067],"about_ca_topic_score_codex":0.0006725769,"about_ca_topic_score_gemma":0.000048099424,"teacher_disagreement_score":0.04230252,"about_ca_system_score_codex":0.00018645149,"about_ca_system_score_gemma":0.00022407848,"threshold_uncertainty_score":0.94501144},"labels":[],"label_agreement":null},{"id":"W4411308989","doi":"10.1038/s41523-025-00763-6","title":"Trends in contralateral breast cancer and contralateral prophylactic mastectomy from 2009 to 2016","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Canada; Cancer Care Ontario","keywords":"Mastectomy; Medicine; Breast cancer; Cancer; Prophylactic Mastectomy; Oncology; General surgery; Internal medicine","score_opus":0.005303011623725965,"score_gpt":0.2699333729662562,"score_spread":0.2646303613425302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411308989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98344207,0.0032063976,0.000088118795,0.009203491,0.0007333737,0.00031388793,0.0023091235,0.000023063687,0.0006804573],"genre_scores_gemma":[0.9926628,0.00020206005,0.00016522764,0.00198493,0.0004773812,0.00041300393,0.00008072588,0.000032961212,0.003980949],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983883,0.00005343804,0.00030186315,0.00066170155,0.00013163289,0.00046304974],"domain_scores_gemma":[0.99931055,0.0000105695835,0.000072434166,0.00033775344,0.00013128179,0.00013743741],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007420384,0.0002824792,0.00029163944,0.00019730517,0.000068643865,0.000071786046,0.0001999207,0.00019720987,0.0006833151],"category_scores_gemma":[0.0000055662526,0.00026012538,0.00007150522,0.00032132544,0.000096430194,0.000018668406,0.00010972572,0.00016074385,0.000007648346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022489193,0.00013667812,0.37801784,0.00005545468,0.00037475282,0.000017998807,0.00028200683,0.0008804026,0.2123848,0.00003945833,0.019467128,0.38609454],"study_design_scores_gemma":[0.0028195507,0.000044790184,0.97498095,0.00015505531,0.00006469373,0.000032069576,0.000029729143,0.00014899006,0.010149231,0.00008418877,0.011110118,0.00038062083],"about_ca_topic_score_codex":0.0061555547,"about_ca_topic_score_gemma":0.0036354165,"teacher_disagreement_score":0.5969631,"about_ca_system_score_codex":0.00028853543,"about_ca_system_score_gemma":0.00039680843,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W4412166029","doi":"10.1038/s41523-025-00768-1","title":"Advancing equitable access to innovation in breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Agence Nationale de la Recherche; European Commission; Equipex; Health Research Board","keywords":"Breast cancer; Business; Oncology; Medicine; Cancer; Internal medicine","score_opus":0.19157179230998192,"score_gpt":0.46597159629673846,"score_spread":0.27439980398675656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412166029","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45995486,0.0030522707,0.0068486175,0.50688034,0.0035409657,0.0016949694,0.003084233,0.00013877888,0.01480497],"genre_scores_gemma":[0.9191792,0.00028861003,0.0005649324,0.075621314,0.00070223253,0.0012951553,0.000029725234,0.00005014112,0.002268661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952045,0.00010069529,0.0031048122,0.000723065,0.00010397579,0.0007629703],"domain_scores_gemma":[0.9980214,0.000195754,0.00097168796,0.00046110837,0.00022102922,0.00012899036],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00616599,0.00023179076,0.00082199543,0.0011675959,0.00017470159,0.00017956267,0.00047868278,0.00015094013,0.002578104],"category_scores_gemma":[0.0004181101,0.00030624232,0.00005885327,0.0019177945,0.00003369841,0.0012110189,0.00019901655,0.0002274328,0.00041076448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007669809,0.00009353186,0.8369439,0.0004592824,0.000062043524,9.403942e-7,0.0005055618,0.005961458,0.000051271512,0.041722775,0.10483064,0.009291897],"study_design_scores_gemma":[0.0010489691,0.000008686547,0.9232527,0.00069835316,0.000007181114,0.000005587368,0.00027385104,0.0025947264,0.00003112144,0.0067694196,0.064882085,0.0004272972],"about_ca_topic_score_codex":0.02344905,"about_ca_topic_score_gemma":0.004647302,"teacher_disagreement_score":0.45922437,"about_ca_system_score_codex":0.0030292496,"about_ca_system_score_gemma":0.00071205304,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W4412521196","doi":"10.1038/s41523-025-00783-2","title":"Personalized ctDNA monitoring in metastatic HR+/HER2− breast cancer patients during endocrine and CDK4/6 inhibitor therapy","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University Health Network; St Mary's Hospital Centre; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Oncology; Circulating tumor DNA; Endocrine system; Clearance; Clinical trial; Cancer; Breast cancer; Urology; Hormone","score_opus":0.006896806610269056,"score_gpt":0.26723096116695855,"score_spread":0.2603341545566895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412521196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98858505,0.008820363,0.000009835651,0.00069991156,0.0006558401,0.00030513434,0.00074480806,0.0000123158625,0.00016671816],"genre_scores_gemma":[0.9874812,0.01091696,0.00006564027,0.00029449424,0.00051504484,0.00026619146,0.00003593182,0.000036134803,0.00038842333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866414,0.000038752878,0.0002716035,0.00048869493,0.00015002854,0.00038675402],"domain_scores_gemma":[0.9994283,0.000019449677,0.00008812484,0.0002202495,0.00014115016,0.000102780476],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00006285179,0.00025979127,0.0002677297,0.00009976098,0.000098671815,0.000054186847,0.00014229966,0.00007488539,0.00010992478],"category_scores_gemma":[0.00001528016,0.00025374678,0.000076765486,0.00017181505,0.000087211054,0.000011640052,0.00013353322,0.0001324115,0.0000014204618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008677999,0.00019735386,0.8897336,0.00010593634,0.00018507241,0.000008088846,0.00012089921,0.00012230602,0.07767151,0.00002338477,0.0004928102,0.030471247],"study_design_scores_gemma":[0.0051107504,0.00004846667,0.9449384,0.00022436083,0.00003970895,0.00001941928,0.00008030972,0.000034234916,0.043642715,0.00003320931,0.0054899394,0.0003384445],"about_ca_topic_score_codex":0.0023739147,"about_ca_topic_score_gemma":0.0005335917,"teacher_disagreement_score":0.055204857,"about_ca_system_score_codex":0.00018165524,"about_ca_system_score_gemma":0.00022534314,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W4412626262","doi":"10.1038/s41523-025-00796-x","title":"The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer","year":2025,"lang":"en","type":"review","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"National Cancer Institute; Office of Defense Programs; Cancer Research UK; National Institutes of Health; Royal Marsden NHS Foundation Trust; Breast Cancer Research Foundation; U.S. Department of Defense","keywords":"Breast cancer; Immunotherapy; Hormone receptor; Hormone; Oncology; Cancer; Medicine; Internal medicine; Receptor; Cancer immunotherapy; Cancer research","score_opus":0.010740190256175721,"score_gpt":0.3146805826261346,"score_spread":0.30394039236995885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412626262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005861722,0.98730534,0.00007782123,0.0020637843,0.0009830309,0.0025218693,0.006842847,0.000031345662,0.000115314906],"genre_scores_gemma":[0.00019751335,0.99527764,0.000033341545,0.0002870741,0.00086417113,0.0013882695,0.00028293347,0.00007736641,0.0015916864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979452,0.00011955909,0.0007416744,0.0004932253,0.00030613292,0.00039421726],"domain_scores_gemma":[0.9983516,0.00022493134,0.00063441816,0.00041385088,0.00029163592,0.0000835847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027826036,0.0004910467,0.0014520735,0.00016614526,0.0002546992,0.000051830695,0.00021693861,0.00037577518,0.00025299663],"category_scores_gemma":[0.00000876843,0.00032043643,0.0006862047,0.00041516137,0.00028077193,0.00008053698,0.00004104127,0.0002936832,0.0000016242816],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005148477,0.0000571251,0.000027185104,0.0045562363,0.0022431337,9.0685666e-7,0.000058385947,3.5684334e-7,0.00036980995,0.000024905778,0.0057660094,0.98174745],"study_design_scores_gemma":[0.004493607,0.00016770803,0.007872995,0.016784007,0.0022540165,0.00018707133,0.000047705846,0.000009834596,0.000063947926,0.0000121869,0.9676824,0.0004245092],"about_ca_topic_score_codex":0.0017780585,"about_ca_topic_score_gemma":0.0000730447,"teacher_disagreement_score":0.98132294,"about_ca_system_score_codex":0.0006794745,"about_ca_system_score_gemma":0.0016328403,"threshold_uncertainty_score":0.9999248},"labels":[],"label_agreement":null},{"id":"W4413803778","doi":"10.1038/s41523-025-00821-z","title":"Prognostic and predictive capacity of tumor infiltrating lymphocytes in the MA.20 regional node radiotherapy trial","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; University Health Network; Queen's University; University of British Columbia","funders":"Göteborgs Universitet; Canadian Cancer Society","keywords":"Radiation therapy; Node (physics); Medicine; Oncology; Internal medicine; Engineering","score_opus":0.017702037874718975,"score_gpt":0.2820940149337266,"score_spread":0.26439197705900763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413803778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045545,0.0028920914,0.00008953691,0.0046461276,0.00019891707,0.00091295777,0.00010897659,0.000015900949,0.0006800203],"genre_scores_gemma":[0.996404,0.00036439707,0.00019526217,0.0024919587,0.00024380043,0.00021469625,0.000007662734,0.000009695881,0.00006853647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990678,0.00007997074,0.0002747501,0.0001986563,0.00021200826,0.00016680175],"domain_scores_gemma":[0.9994494,0.00018489729,0.00010529392,0.00016494561,0.000067982444,0.00002747871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028127342,0.00012784338,0.00026410285,0.00009199196,0.000053657855,0.000015206464,0.00008933898,0.00005852995,0.00007170214],"category_scores_gemma":[0.000032480624,0.00008550357,0.00007277102,0.0002977152,0.0002473099,0.00005850324,0.000009782046,0.00013439333,1.5618072e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28029376,0.00071004784,0.6011011,0.0006075755,0.00089203013,0.000024370227,0.005003531,0.00005610001,0.04823222,0.0002965507,0.0040910398,0.05869168],"study_design_scores_gemma":[0.054782245,0.00041401666,0.93740207,0.0010690952,0.00013008526,0.0002401238,0.00057378237,0.0008374758,0.0015058764,0.000084704174,0.00282048,0.00014005577],"about_ca_topic_score_codex":0.0015179608,"about_ca_topic_score_gemma":0.00019500044,"teacher_disagreement_score":0.33630097,"about_ca_system_score_codex":0.00022323418,"about_ca_system_score_gemma":0.00046580937,"threshold_uncertainty_score":0.34867343},"labels":[],"label_agreement":null},{"id":"W4414478250","doi":"10.1038/s41523-026-00955-8","title":"Multimodal analysis of a rare BARD1 missense variant suggests its pathogenicity is conditional","year":2025,"lang":"en","type":"preprint","venue":"npj Breast Cancer","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Faculty of Medicine and Health, University of Sydney; Instituto de Salud Carlos III; Canadian Institutes of Health Research; Merck Canada; McGill University Health Centre; McGill University","keywords":"Missense mutation; Germline; Loss of heterozygosity; Proband; Breast cancer; Germline mutation; Heteroduplex; Tamoxifen","score_opus":0.009118949755469785,"score_gpt":0.27419742798817215,"score_spread":0.26507847823270236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414478250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8144821,0.0075081238,0.0020990646,0.0011870781,0.0009551811,0.0005906624,0.17221239,0.000020657826,0.0009447408],"genre_scores_gemma":[0.9906574,0.0021483668,0.00038753584,0.0011363687,0.00048670484,0.00014499901,0.004479315,0.000026233543,0.0005331106],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99810743,0.000060916787,0.00045718867,0.000825981,0.00025455025,0.0002939439],"domain_scores_gemma":[0.9981446,0.000042527106,0.00032036367,0.00071717874,0.000629779,0.00014554724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000127255,0.00036106756,0.0006266886,0.00020161537,0.00006206881,0.000033519125,0.00035373447,0.0005422294,0.000809204],"category_scores_gemma":[0.00006343715,0.00038978478,0.0006439168,0.0002459002,0.0000866021,0.000002163239,0.0006263666,0.0002544498,0.0000034972663],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051987134,0.002682818,0.095320724,0.003370617,0.064222775,0.00060814916,0.0013293304,0.35451883,0.32882947,0.0020527644,0.10976029,0.03210552],"study_design_scores_gemma":[0.005511031,0.00024478024,0.74249315,0.00088638644,0.018037667,0.00023517307,0.00012555507,0.043430164,0.13206373,0.00091618573,0.052409478,0.0036466883],"about_ca_topic_score_codex":0.0013854651,"about_ca_topic_score_gemma":0.0007746653,"teacher_disagreement_score":0.64717245,"about_ca_system_score_codex":0.00011796653,"about_ca_system_score_gemma":0.0012607767,"threshold_uncertainty_score":0.9998554},"labels":[],"label_agreement":null},{"id":"W4414662508","doi":"10.1038/s41523-025-00820-0","title":"Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Cancer Institute; NIHR Cambridge Biomedical Research Centre; Department of Health and Social Care; Medical Research Council; Universiti Malaya; Breast Cancer Research Foundation; National Research Foundation Singapore; Universiti Kebangsaan Malaysia; National Medical Research Council; National Research Foundation; Wellcome Trust; Cancer Research UK; Universiti Sains Malaysia; Government of Canada; AstraZeneca; Yayasan Sime Darby; Canadian Institutes of Health Research; Gray Foundation; National Institutes of Health; Kementerian Kesihatan Malaysia; Hospital Universiti Sains Malaysia; National Institute for Health and Care Research; Genome Canada; Fondation du cancer du sein du Québec; Ovarian Cancer Research Fund","keywords":"Polygenic risk score; Breast cancer; Confidence interval; Risk assessment; Population; Cancer; Lifetime risk; Risk factors for breast cancer","score_opus":0.005676353202433707,"score_gpt":0.2574515463959195,"score_spread":0.2517751931934858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414662508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608795,0.009720454,0.0019457607,0.0018402579,0.0015344688,0.00097120873,0.022585567,0.000041787833,0.00048101056],"genre_scores_gemma":[0.9934109,0.0035805167,0.0003059855,0.00037070454,0.0006247967,0.00092739164,0.000119602766,0.000053864034,0.00060627935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804974,0.00011095423,0.00037420567,0.000830391,0.00015889082,0.00047580767],"domain_scores_gemma":[0.9989805,0.000017853396,0.00019766272,0.0004724049,0.00020071029,0.00013083169],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00027702868,0.00029958627,0.00026687593,0.00016220959,0.00023417265,0.000050309984,0.00022866979,0.0003263732,0.00015655419],"category_scores_gemma":[0.00003928887,0.00031209944,0.00013131938,0.00035386736,0.00018675167,0.000018610357,0.00011223485,0.00024156253,0.0000022104905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008540502,0.00007233905,0.64691466,0.000105942476,0.00054574996,0.0000021807768,0.00026767747,0.0011693565,0.03182161,0.000045991077,0.0057415,0.31245896],"study_design_scores_gemma":[0.0025079944,0.000053205327,0.98819304,0.0001270488,0.00027466728,0.00005457501,0.00019603243,0.0008934662,0.0023448225,0.00031255384,0.0047186557,0.00032392543],"about_ca_topic_score_codex":0.0028827614,"about_ca_topic_score_gemma":0.0066116415,"teacher_disagreement_score":0.3412784,"about_ca_system_score_codex":0.0004983579,"about_ca_system_score_gemma":0.0011005983,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W4415619960","doi":"10.1038/s41523-025-00824-w","title":"A core outcome set for locoregional treatment reporting in neoadjuvant systemic breast cancer treatment trials","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Sault Area Hospital; Jewish General Hospital; University of Toronto; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache","funders":"National Institute for Health and Care Research; NIHR Bristol Biomedical Research Centre; Association of Breast Surgery; Department of Health and Social Care; Royal College of Surgeons of England; Breast Cancer Research Foundation","keywords":"Delphi method; Breast cancer; Outcome (game theory); Neoadjuvant therapy; Systemic therapy; Consistency (knowledge bases); Radiation therapy; Delphi","score_opus":0.5005127874530704,"score_gpt":0.5781129949305013,"score_spread":0.0776002074774309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415619960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8425215,0.005992607,0.001040705,0.099273995,0.004802839,0.022086479,0.011812328,0.0010229019,0.011446633],"genre_scores_gemma":[0.98054856,0.0009954647,0.00019772247,0.00026008912,0.0007726814,0.010398236,0.000036396188,0.000038555238,0.006752266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541336,0.00040610167,0.001902616,0.00072621653,0.00064517936,0.00090651395],"domain_scores_gemma":[0.99704266,0.00079241203,0.001111566,0.00043648446,0.0004111457,0.00020573207],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003575457,0.0003553769,0.0011524413,0.00035700024,0.00040891525,0.00012364423,0.00037848018,0.00026583625,0.00056969415],"category_scores_gemma":[0.00045895006,0.00027393084,0.00043711465,0.0007077982,0.00024527873,0.00015890734,0.000062764586,0.00015541904,0.0000074792524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010067783,0.00037506365,0.63391995,0.00017019079,0.0003548564,0.000106296786,0.0031569412,0.00027159025,0.00045957702,0.002981818,0.0058497577,0.35134718],"study_design_scores_gemma":[0.029536758,0.00087960594,0.718543,0.008035922,0.0015038407,0.0009774865,0.025592675,0.0034919223,0.0015657671,0.00864131,0.19797802,0.0032536774],"about_ca_topic_score_codex":0.15737307,"about_ca_topic_score_gemma":0.053206094,"teacher_disagreement_score":0.3480935,"about_ca_system_score_codex":0.008407017,"about_ca_system_score_gemma":0.003061042,"threshold_uncertainty_score":0.9999713},"labels":[],"label_agreement":null},{"id":"W4417311889","doi":"10.1038/s41523-025-00874-0","title":"The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Breast cancer; Estrogen receptor; Circulating tumor cell; Fluorescence in situ hybridization; Estrogen; Stage (stratigraphy); Disease; Proportional hazards model; Adjuvant therapy","score_opus":0.00607237937998069,"score_gpt":0.2828771518055007,"score_spread":0.27680477242552004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417311889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96719056,0.023826929,0.000004985697,0.0033384634,0.00034477923,0.000805073,0.0007402986,0.000018653373,0.0037302454],"genre_scores_gemma":[0.99821573,0.0009668817,0.000045209184,0.00021793494,0.00015777702,0.00022809352,0.000015716958,0.00001955596,0.00013309775],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851114,0.00013299315,0.00041069806,0.00024646093,0.00038728086,0.0003114529],"domain_scores_gemma":[0.99890506,0.00011881403,0.00032476304,0.00028455633,0.00031686225,0.000049937848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038538917,0.00017252192,0.00037654952,0.00007368489,0.00011810834,0.00001554463,0.00019286563,0.00006797879,0.00017050924],"category_scores_gemma":[0.000017428656,0.00010108442,0.00015311486,0.00058621226,0.00014935325,0.00004691198,0.000058364287,0.00021032519,0.0000010621657],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080288184,0.00034079977,0.42235976,0.00020766312,0.0002703098,0.000006126176,0.0010412288,0.0001003989,0.101755954,0.00020521122,0.000556739,0.47235292],"study_design_scores_gemma":[0.0029514749,0.00010006309,0.8409961,0.0028888816,0.00058642315,0.00005494532,0.003367332,0.00038807897,0.14205043,0.00009515398,0.0062824083,0.00023874924],"about_ca_topic_score_codex":0.007593842,"about_ca_topic_score_gemma":0.00068634195,"teacher_disagreement_score":0.47211418,"about_ca_system_score_codex":0.00023855582,"about_ca_system_score_gemma":0.00062507356,"threshold_uncertainty_score":0.9990147},"labels":[],"label_agreement":null},{"id":"W4417359648","doi":"10.1038/s41523-025-00871-3","title":"Author Correction: Advancing equitable access to innovation in breast cancer","year":2025,"lang":"en","type":"erratum","venue":"npj Breast Cancer","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Breast cancer; MEDLINE; Work (physics); Cancer","score_opus":0.015231374146467884,"score_gpt":0.33255533212520094,"score_spread":0.3173239579787331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417359648","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02384169,0.06114693,0.0034610461,0.22370104,0.5179108,0.00865247,0.03944331,0.00079983193,0.12104289],"genre_scores_gemma":[0.12222529,0.010149261,0.00034586698,0.018249473,0.028065883,0.010758429,0.005460724,0.0005545593,0.8041905],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639666,0.00007674474,0.0007160294,0.0013549825,0.00042365486,0.001031946],"domain_scores_gemma":[0.9979116,0.00001963583,0.0003807934,0.00070544245,0.00084366265,0.00013888597],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025191042,0.0007443032,0.0007559112,0.00057885924,0.00024811973,0.0001424183,0.000639895,0.00073579187,0.0006332335],"category_scores_gemma":[0.00006135571,0.00076259585,0.00014646906,0.0017733381,0.00008072091,0.00003888415,0.00087639014,0.00065285375,0.000015897649],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005443653,0.000111875015,0.026906399,0.00022899477,0.0003243892,0.000008045211,0.000070465874,0.0007040419,0.00089839334,0.0000115662715,0.9133389,0.05685255],"study_design_scores_gemma":[0.0012375386,0.000044818255,0.2810223,0.002353735,0.00021574699,0.00008915603,0.000117492076,0.000056976787,0.0013732144,0.000032645872,0.71239626,0.0010601175],"about_ca_topic_score_codex":0.010559221,"about_ca_topic_score_gemma":0.013600293,"teacher_disagreement_score":0.6831476,"about_ca_system_score_codex":0.0014641375,"about_ca_system_score_gemma":0.0022688992,"threshold_uncertainty_score":0.9994825},"labels":[],"label_agreement":null},{"id":"W7116399323","doi":"10.1038/s41523-025-00856-2","title":"Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases","year":2025,"lang":"en","type":"article","venue":"npj Breast Cancer","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Breast Cancer Research Foundation","keywords":"Breast cancer; Clinical trial; Cancer; Central nervous system; Radiation therapy; Systemic therapy; Translational research","score_opus":0.028536240674687137,"score_gpt":0.33006321745542,"score_spread":0.30152697678073287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116399323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777189,0.007244552,0.00017202705,0.003232609,0.00023720428,0.002333144,0.008642509,0.00007378454,0.00034526165],"genre_scores_gemma":[0.9964864,0.00065183575,0.00085271493,0.00010340602,0.00018805891,0.001022498,0.000085523774,0.0000364316,0.0005730974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982193,0.00005436379,0.00024092039,0.00052942784,0.00035487002,0.00060109695],"domain_scores_gemma":[0.998844,0.00014297508,0.0000702122,0.00026093295,0.0004500683,0.00023177093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001227598,0.0003192602,0.00052966946,0.00016245905,0.00029476496,0.00016799125,0.00005765423,0.0000738137,0.000046853485],"category_scores_gemma":[0.000006482878,0.00020461924,0.000070806505,0.00021100356,0.00025665696,0.00020904207,0.000047957958,0.00011597389,6.1701036e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010112932,0.0018129883,0.51243263,0.0037921711,0.0043317685,0.000068144225,0.0010239144,0.000099801146,0.00028674325,0.013945205,0.0011482057,0.4509455],"study_design_scores_gemma":[0.011515811,0.00079378375,0.9786069,0.0011933736,0.0010918614,0.00016613374,0.0024877915,0.00013697069,0.000120619516,0.000032701355,0.0036307492,0.0002233133],"about_ca_topic_score_codex":0.011835379,"about_ca_topic_score_gemma":0.0017301575,"teacher_disagreement_score":0.46617424,"about_ca_system_score_codex":0.0007336557,"about_ca_system_score_gemma":0.0009181126,"threshold_uncertainty_score":0.9947449},"labels":[],"label_agreement":null}]}